Here and Now: Inspiring Stories of Cancer Survivors --
by Elena Dorfman, Heidi Schultz Adams
Kathy's Hats: A Story of Hope Kathy's Hats: A Story of Hope
by Trudy Krisher
My Mommy's Cancer
by Cindy Klein Cohen
Beating Cancer With Nutrition
by Patrick Quillin
A Cancer Battle Plan: Six Strategies for Beating Cancer, from a Recovered "Hopeless Case"
by Anne E. Frahm, David J. Frahm
How to Fight Cancer & Win
by William L. Fischer
What to Eat if You Have Cancer
by Daniella Chace
The Cure for All Cancers: Including over 100 Case Histories of Persons Cured
by Hulda Regehr Clark
Just Get Me Through This: The Practical Guide to Breast Cancer
by Deborah A. Cohen

    Hodgkin's Lymphoma





    What's up doc? Help fight cancer in children 14 Mar 2006
    MetroWest Daily News, ...of leukemia) went from 4 percent in 1960 to 77 percent in 1990, AML (another type of leukemia) went from 20 percent to 40 percent, Hodgkin's lymphoma from 50 ...

    Susan G. Komen Race for a cure 14 Mar 2006
    Jackson Clarion Ledger, ...free. "I found a lot of strength from looking at my daughter, who had Hodgkin's lymphoma the year before I was diagnosed," she said. ...

    Fund-raiser says thank you to cancer unit 14 Mar 2006
    Bury Free Press, Moira Reeve was so impressed with the speed and quality of her treatment for non-hodgkin's lymphoma at West Suffolk Hospital she decided to hold a New Year's ...

    Primary Non-Hodgkin's Lymphoma of Bone in Children Mar 9, 2006
    Journal of Bone and Joint Surgery Background: Primary non-Hodgkin's lymphoma of bone, often more simply referred to as primary lymphoma of bone, is a rare subset of non-Hodgkin's lymphoma in ...

    Shorter therapy helps non-Hodgkin's lymphoma patients Feb 15, 2006
    ABC Regional Online, A new study has found that survival rates among elderly patients affected by non-Hodgkin's lymphoma has increased by using a different treatment method. ...

    Drug Shows Promise For Non-Hodgkin's Lymphoma Patients Feb 16, 2006
    INDYchannel.com, Doctors have a new weapon in the fight against non-Hodgkin's lymphoma, 6News' Stacia Matthews reported Thursday. The Food and Drug ...

    Ernie Johnson Jr. has non-Hodgkin's lymphoma Feb 22, 2006
    Atlanta Journal Constitution (subscription), Turner Sports announcer Ernie Johnson Jr. said today he will undergo treatment for non-Hodgkin's Lymphoma this summer. Johnson, host ...

    Allos Therapeutics Reports 2005 Financial Results Mar 6, 2006
    PR Newswire (press release), ...the presentation of interim results from a Phase 1/2 single-agent study of PDX in patients with relapsed or refractory non-Hodgkin's lymphoma and Hodgkin's ...

    Genentech and Biogen Legal Troubles - When It Rains It Pours Mar 8, 2006
    OpEdNews ...by Evelyn Pringle. Rituxan gained FDA approval in 1997, as a treatment for a certain type of non-Hodgkin's lymphoma. Roughly 12,760 ...

    VGX and Dowpharma sign cancer compound agreement Mar 10, 2006
    In-PharmaTechnologist.com, ...development of a novel cancer compound currently in pre-clinical development that initial clinical studies will target individuals with Non-Hodgkin's Lymphoma. ...

    Mom goes bald to aid cancer research Mar 12, 2006
    DetNews.com, Faolan MacBeth's death from non-Hodgkin's lymphoma four years ago inspired her parents' involvement with St. Baldrick's. See full image. F aolan died. ...

    A strike against cancer Mar 13, 2006
    Centre Daily Times, The charity event is named in honor of Matt Knepp, an avid bowler who lost his battle with non-Hodgkin's lymphoma six years ago today. ...

    Cell Therapeutics, Inc. (CTI) Reports 2005 Fourth Quarter and Year ... Mar 9, 2006
    MSN Money ...applications in the United States and Europe and on reporting the interim analysis for the pixantrone phase III trial in non-Hodgkin's lymphoma," stated James A ...

    Favrille Announces $45 Million Financing to Support Clinical ... Mar 7, 2006
    PR Newswire (press release), ..."This will enable us to continue our clinical development of FavId for B-cell non-Hodgkin's lymphoma (NHL) while aggressively preparing for its commercial ...

    Rituxan earns FDA approval for aggressive non-Hodgkin's Feb 11, 2006
    Cancerfacts.com, ...and marketed by Genentech and Biogen-Idec for use in the first-line treatment of patients with an aggressive form of non-Hodgkin's lymphoma, called diffuse ...

    METRO DETROIT CANCER FUND-RAISER: A long walk for a long fight Mar 1, 2006
    Detroit Free Press, About 750,000 Americans and 23,000 Michiganders currently live with leukemia, Hodgkin's or non-Hodgkin's lymphoma or myeloma, all forms of blood cancer. ...

    Lady Elspeth Campbell: The Empress Ming Mar 11, 2006
    Independent, Elspeth displayed her stoicism when Sir Menzies was diagnosed four years ago with Non-Hodgkin's lymphoma, a cancer which attacked his hip and led to months of ...

    FDA Approves Rituxan (Rituximab) Plus CHOP or Other Anthracycline ... Feb 10, 2006
    DG News Rituxan(R) (rituximab) for use in the first-line treatment of patients with diffuse large B-cell, CD20-positive, non-Hodgkin's lymphoma, in combination with ...

    Off-label usage of drugs gets scrutinized Mar 3, 2006
    San Diego Union Tribune, Use: To treat some forms of non-Hodgkin's lymphoma. Approved Tuesday for rheumatoid arthritis. Cost: For cancer, about $20,000 for a six-treatment course. ...

    High lung cancer rate seen in North Toledo Mar 11, 2006
    Toledo Blade, ...significant. One - non-Hodgkin's lymphoma - was even found to occur far less frequently than expected in the Lagrange area. The ...

    BioCryst Initiates Intravenous Peramivir Phase I Clinical Trial Mar 9, 2006
    International News Service, Fodosine(TM) has been granted Orphan Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL ...

    COMUNICADO: Lilly Launches Phase III Trial of Targeted Cancer ... Mar 9, 2006
    Europa Press, In addition to glioblastoma, enzastaurin is also being studied in multiple other tumor types, including non-Hodgkin's lymphoma, colorectal cancer, non-small ...

    Genentech, Biogen get added Rituxan OK Mar 1, 2006
    BusinessWeek In February, the companies gained FDA approval to market Rituxan to treat diffuse large B-cell lymphoma, an aggressive type of non-Hodgkin's lymphoma. ...

    Amy Tan -- to music. Novelist's work will be adapted by Opera. Mar 8, 2006
    San Francisco Chronicle, Dalia Rawson, a principal dancer with Ballet San Jose Silicon Valley, has taken a leave from the company after being diagnosed with Hodgkin's lymphoma. ...

    Dying son's plea for justice Mar 10, 2006
    NEWS.com.au, ...by creditors. Joel, 23, who has non-Hodgkin's lymphoma, said he was outraged at the treatment of his mother and Ms Ottaway. "They ...

    Shelton high schoolers compete for Mr. Student Body Mar 12, 2006
    Connecticut Post, Valovcin finally gave his blessing after a worthy cause for the event was found — - raising money for a recent graduate diagnosed with non-Hodgkin's lymphoma ...

    Leukemia Cup races to be held Mar 2, 2006
    Mobile Register, Participants raise funds to find cures for blood cancers such as leukemia, Hodgkin's and non-Hodgkin's lymphoma and myeloma and to improve the lives of ...

    Church is Raising Funds for Teen's Lymphoma Treatment Mar 8, 2006
    International News Service, He was diagnosed with Hodgkin's Lymphoma, a cancer that starts in lymphatic tissue like the lymph nodes and organs that are part of the body's immune and blood ...

    Eli Lilly Launches Phase III Study Of Enzastaurin For Brain Tumor ... Mar 9, 2006
    Trading Markets, In addition to glioblastoma, enzastaurin has been studied in multiple other tumor types, including non-Hodgkin's lymphoma, colorectal cancer, non-small cell ...

    FDA Approves Rituxan (Rituximab), the First Targeted B-Cell ... Mar 1, 2006
    DG News In general, the adverse events observed in patients with RA were similar in type to those seen in patients with non-Hodgkin's lymphoma (NHL). ...

    North Port news briefs Mar 4, 2006
    Charlotte Sun-Herald, For patients with blood cancers, such as non-Hodgkin's lymphoma and multiple myeloma, chemotherapy can be a double-edged sword. ...

    Allos Therapeutics Appoints Paul L. Berns as President and CEO Mar 10, 2006
    PR Newswire (press release), ...under investigation as both a single agent and in combination therapy regimens in patients with non-small cell lung cancer and Non-Hodgkin's lymphoma; and RH1 ...

    Scheduled Combination of Allos Therapeutics' Pralatrexate Plus ... Feb 14, 2006
    PR Newswire (press release), ...these challenging diseases." These data established the superior therapeutic activity of pralatrexate in models of human non-Hodgkin's lymphoma and provide ...

    Scheduled Combination of Allos Therapeutics' Pralatrexate Plus ... Feb 14, 2006
    PharmaLive.com (press release), These data established the superior therapeutic activity of pralatrexate in models of human non-Hodgkin's lymphoma and provide further support for the Phase 1 ...

    MultiVu Video Feed: Rituxan: First FDA-Approved Treatment to ... Feb 10, 2006
    PR Newswire (press release), 10 /PRNewswire/ -- Patients with non-Hodgkin's lymphoma, any cancer of the lymphoid tissue in which lymphocytes proliferate and grow uncontrollably, now have a ...

    FDA approves Rituxan for first-line lymphoma treatment Feb 13, 2006
    Pharmaceutical Business Review ...and Biogen Idec's lymphoma drug Rituxan for use in the first-line treatment of patients with diffuse large B-cell non-Hodgkin's lymphoma, in combination with ...

    Anti-Lymphoma Drug Gets OK for New Use Feb 11, 2006
    HealthCentral.com The Associated Press reports that the US Food and Drug Administration approved a new indication for Rituxan to treat certain types of non-Hodgkin's lymphoma. ...

    CRICKET STARS BACK CANCER SURVIVOR Mar 3, 2006
    Community Newswire, In November 2004, David, 38, was diagnosed with Hodgkin's lymphoma, a blood cancer that affects approximately 1,400 people in the UK each year. ...

    UPDATE 1-Genentech gets FDA OK for Rituxan for arthritis Feb 28, 2006
    Reuters ...(BIIB.O: Quote, Profile, Research) on Tuesday said US regulators have approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis ...

    Rituxan's Expanded Use OKd Mar 1, 2006
    Los Angeles Times, ...and Biogen Idec Inc. on Tuesday said US regulators had approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis. ...

    Genentech gets FDA OK for Rituxan for arthritis Feb 28, 2006
    ABC News Inc. said on Tuesday US regulators have approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis. ...

    Soul legend Lynden David Hall looses battle with cancer Feb 21, 2006
    Black Information Link, By Rob Neil & Matilda MacAttram. Lynden David Hall, singer songwriter, and producer lost a two year battle with Hodgkin's Lymphoma last Tuesday. ...

    Rituxan Gets Added Clearance Feb 13, 2006
    TheStreet.com ...type of immune-system cells. Rituxan is already approved to treat low-grade non-Hodgkin's lymphoma. The FDA approval, announced ...

    Biogen Idec Reports Full Year and Fourth Quarter 2005 Results Feb 15, 2006
    Genetic Engineering News, FDA) has approved RITUXAN for use in the first-line treatment of patients with diffuse large B-cell, CD20-positive, non-Hodgkin's lymphoma, in combination with ...

    -- Online Broadcast of Discovery Health Channel Segment on ... Feb 22, 2006
    Genetic Engineering News, ...with physical examination and CT scan evidence of gross tumor remission, to gain conditional approval of BiovaxID for treating follicular non-Hodgkin's lymphoma ...

    European Regulatory Committee Recommends Orphan Drug Status for ... Feb 14, 2006
    Market Wire (press release) 1D09C3 was previously granted orphan medicinal product designation by the European Commission for Hodgkin's lymphoma and chronic lymphocytic leukemia, a type ...

    Pending Rituxan Arthritis Approval Means Little To Earnings Feb 27, 2006
    Forbes ...supplemental biologics license application], but caution that the FDA may regard the available safety database of non-Hodgkin's lymphoma patients inadequate to ...

    US gives a second life to a major cancer drug Mar 1, 2006
    International Herald Tribune, B cells. These are the ones that run amok in non- Hodgkin's lymphoma, the type of cancer for which Rituxan is approved. But the ...

    Sunlight, vitamin D trade-off explored Mar 8, 2006
    London Free Press, ...that is, not using sunscreen -- may reduce your risk of some big cancers, like breast, prostate, colorectal and non-Hodgkin's lymphoma," said Logan, director ...

    Vitamin D supplements may give benefits of sun without skin cancer ... Mar 8, 2006
    Canada.com, ...unprotected - that is, not using sunscreen - may reduce your risk of some big cancers, like breast, prostate, colorectal and non-Hodgkin's lymphoma," said Logan ...

    Experts debate clear guideline on sun exposure Mar 9, 2006
    CTV.ca, ...out in the sun for unprotected periods of time will reduce your risk of some cancers including breast, prostate, colorectal, ovarian and non-Hodgkin's lymphoma ...

    Celgene's Revlimid Has Upside Long-Term Potential Mar 8, 2006
    Forbes In addition, the Morgan Stanley analyst highlighted Revlimid’s potential in other indications such as leukemia and non-Hodgkin's lymphoma. ...

    Favrille to raise $45 mln from private placement Mar 7, 2006
    Reuters ...said the proceeds will be used to fund the clinical development and commercial launch of its lead product FavId, used to treat a type of non-Hodgkin's lymphoma ...

    Productivity dips at end of 2005 Mar 8, 2006
    San Diego Union Tribune, Favrille said it will use the money to fund the clinical development of its non-Hodgkin's lymphoma treatment, FavId. Delta Air Lines Inc. ...

    FDA Approves Cancer Drug Rituxan Feb 10, 2006
    All Headline News New York, New York (AHN) - The US Food and Drug Administration has approved the drug Rituxan, which is used to treat certain types of non-Hodgkin's lymphoma. ...

    Cancer Drug Approved for Arthritis Sufferers Mar 2, 2006
    WLNS, ...arthritis. The FDA action comes more than eight years after the agency initially approved Rituxan to treat non-Hodgkin's Lymphoma. ...

    FRUIT SELLER SIGNS UP FOR 'BANANA ARMY' Mar 7, 2006
    Community Newswire, ...is the only national charity devoted exclusively to improving treatments, finding cures and learning how to prevent leukaemia, Hodgkin's lymphoma and other ...

    Tanox Reports Fourth Quarter and Full Year 2005 Results Feb 28, 2006
    International News Service, Tanox filed an Investigational New Drug (IND) application for TNX-650 for the treatment of Hodgkin's lymphoma that is refractory to chemotherapy and/or ...

    Lilly starts phase 3 trial of enzastaurin Mar 9, 2006
    United Press International Lilly is studying whether enzastaurin could be useful in treating other cancers, including non-Hodgkin's lymphoma, colorectal cancer and non-small cell lung ...

    Combination therapy improves Acquired Immunodeficiency Syndrome ... Feb 27, 2006
    News-Medical.net, Society, the study reveals that combination therapy showed the greatest benefit for HIV patients suffering from aggressive malignant non-Hodgkin's lymphoma. ...

    Author's treaty book was evidence in US Supreme Court case Mar 8, 2006
    Duluth News Tribune, Satz, 62, died Tuesday at Fairview University Medical Center in Minneapolis after battling non-Hodgkin's lymphoma, funeral director Jerry Speckien confirmed in ...

    Superintendent Sponseller says he has lymphoma Feb 25, 2006
    Hagerstown Morning Herald, Chambersburg Area School District Superintendent Edwin H. Sponseller was diagnosed Monday with non-Hodgkin's lymphoma, a cancer of the lymphatic system, he ...

    Nailers facing a busy final run in Mar 8, 2006
    Belper Today, Jamie, who was diagnosed with Hodgkin's Lymphoma, a cancer of the lymph glands, in November last year is currently undergoing a course of chemotherapy at Kings ...

    Louisville has high hopes for Genentech Mar 7, 2006
    Louisville Courier-Journal, It has built its recent success on blockbuster cancer drugs, including Rituxan for non-Hodgkin's lymphoma and Avastin for colon cancer. ...

    Soul singer Hall loses cancer battle Feb 16, 2006
    RTE.ie, Soul singer Lynden David Hall has died after losing his two-year battle with Hodgkin's Lymphoma. He was 31. London-born Hall won ...

    STARR REPORT Mar 10, 2006
    New York Post, Gotham Comedy Club tonight through Sunday. He's recently recovered from non- Hodgkin's lymphoma. More ratings: The season premiere ...

    RITUXAN: FIRST FDA-APPROVED TREATMENT TO IMPROVE SURVIVAL FOR ... Feb 22, 2006
    PR Newswire (press release), ...in combination with chemotherapy becomes the first FDA-approved treatment to improve survival for patients with this type of Non-Hodgkin's Lymphoma since the ...

    Stem Cell Transplant for High Risk Patients with Lymphoma Feb 15, 2006
    Community Dispatch (press release) If you have been diagnosed with Non-Hodgkin's lymphoma or Hodgkin's Disease you may be able to participate in a stem cell transplant clinical trial designed to ...

    Teen fights for her life and education Mar 6, 2006
    North County Times, Alex continued her schooling from home after she was diagnosed with Hodgkin's lymphoma, a sometimes fatal malignancy that affects two in 10,000 people. ...

    Sask. to expand list of occupational illnesses linked to ... Feb 28, 2006
    StarPhoenix, REGINA -- Being diagnosed with non-Hodgkin's lymphoma in 2002 was stressful enough for Regina firefighter Ivan Wagner. Discovering ...

    Painting Blog Archives Mar 6, 2006
    About - News & Issues, I know this from extensive research after being diagnosed with non-Hodgkin's lymphoma. It is the second fastest growing cancer type in the US". ...

    Making the case for a title Mar 9, 2006
    Sioux Falls Argus Leader, ...play. But during her freshman year, Dan Case was diagnosed with non-Hodgkin's lymphoma and spent much of his time in the hospital. ...

    Meet a card-carrying angel Mar 9, 2006
    Orlando Sentinel, ...disease's darkness. His formal training in battling cancer began in 1997 when doctors diagnosed his non-Hodgkin's lymphoma. In the ...

    Shearing is sharing in cancer fight Mar 10, 2006
    Detroit Free Press, For Walled Lake resident Emily MacBeth, 33, shaving her head is an act of love for her daughter Faolan, who died four years ago from non-Hodgkin's lymphoma. ...

    Rituxan OK'd for Rheumatoid Arthritis Mar 1, 2006
    WebMD ...used to treat cancer. It's been used since 1997 to treat non-Hodgkin's lymphoma, a cancer of the lymph nodes. "The FDA approval ...

    AROUND THE TOWNS Feb 23, 2006
    Freeport Journal Standard, ...u “Lymphoma: Aggressive Non-Hodgkin's Lymphomaâ€? with Dr. Henry Fung Rush University Medical Center. u “Lymphoma: Indolent ...

    Roche halts enrollment in Avastin trial Feb 13, 2006
    Pharma Times (subscription), Meanwhile, Roche and Genentech's flagship product, the non-Hodgkin's lymphoma treatment MabThera/Rituxan (rituximab), which is also marketed in the US with ...

    Genitope Corporation Initiates Clinical Trial to Evaluate MyVax(R) ... Feb 27, 2006
    PR Newswire (press release), ..."Active immunotherapy, sometimes called a cancer vaccine, has shown considerable promise in treating non-Hodgkin's lymphoma," said Dan W. Denney, Jr., Ph.D ...

    'Killer Cramps' Not Necessarily Serious Mar 7, 2006
    Gilroy Dispatch (subscription), Several reports also suggest a link between endometriosis and a higher risk for breast cancer, non-Hodgkin's lymphoma and melanoma. ...

    Cell Therapeutics, Inc. CEO Talks About Lung Cancer Treatments for ... Mar 9, 2006
    PharmaLive.com (press release), ...lung and ovarian cancers, the potential failure of pixantrone to prove safe and effective for relapsed aggressive non-Hodgkin's lymphoma, determinations by ...

    PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on ... Mar 9, 2006
    Business Wire (press release), PRAECIS has a novel MetAP-2 inhibitor, PPI-2458, in clinical development for cancer indications, including non-Hodgkin's lymphoma and solid tumors, as well as ...

    Anti-Tumor Effects Demonstrated With Enriched Tumor Antigen ... Feb 21, 2006
    DG News ...reported progress in the development of targeted immunotherapy for Epstein Barr virus (EBV)-positive Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). ...

    Mac Fights Back Feb 17, 2006
    BurlingtonFreePress.com, ...one tough athlete. Now, she is dealing with another competitor, an insidious one at that: Hodgkin's lymphoma. The popular junior ...

    Hoping for a miracle Feb 17, 2006
    Newsday, ...illness. Christine Pechera, 34, of Los Angeles, was diagnosed three years ago with non-Hodgkin's lymphoma, a cancer of lymphoid tissue. ...

    Stem cell issue is causing headaches for GOP Mar 3, 2006
    Chicago Tribune, ...override a presidential veto.". Specter, recovering from Hodgkin's lymphoma, views the issue in deeply personal terms. "I feel very ...

    GPC Biotech's anticancer drug 1D09C3 recommended for 'orphan drug' ... Feb 14, 2006
    Forbes The drug was previously granted orphan medicinal product designation by the European Commission for Hodgkin's lymphoma and chronic lymphocytic leukemia, a type ...

    Saloky's dad inspiration for fundraiser Feb 28, 2006
    phillyBurbs.com, Former swimmer Brian Crooks had a sister suffer from leukemia and both Eric Mayer and Caroline Bedesem had nuclear family members battle non-Hodgkin's lymphoma ...

    Koivu's Nightmare Gives Way to Dream Feb 26, 2006
    Washington Post, Saku Koivu, center, whose case of non-Hodgkin's lymphoma was diagnosed in 2001, leads the Olympic men's hockey tournament in points. ...

    Why Olympian must hit ground running to fight twin challenge Mar 2, 2006
    Independent, An affable and approachable politician, Ming - as he is invariably known - overcame cancer after he was diagnosed with non-Hodgkin's lymphoma in 2002. ...

    Key Events Nearing for Biogen Idec, but Upside Looks Limited Feb 15, 2006
    TheStreet.com ...million. The company's other main product line is the oncology treatment Rituxan, which is indicated for non-Hodgkin's lymphoma. ...

    Genentech gets FDA OK for Rituxan for arthritis Feb 28, 2006
    Reuters ...(BIIB.O: Quote, Profile, Research) on Tuesday said US regulators have approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis ...

    Biogen 4th-qtr profit nearly doubles Feb 15, 2006
    MSN Money ...return to the US market, said on Wednesday its fourth-quarter profit nearly doubled on increased sales of its older MS drug and one for non-Hodgkin's lymphoma. ...

    Rheumatoid Arthritis Drug Is Approved Feb 28, 2006
    New York Times, ...later merged with Biogen. The drug was licensed to Genentech and was approved for non-Hodgkin's lymphoma in 1997. The drug is Genentech's ...

    TECH TICKER Mar 1, 2006
    San Jose Mercury News, ...candidates for Rituxan. Rituxan has been approved by the FDA since 1997 as a treatment for non-Hodgkin's lymphoma. Affymetrix stock ...

    Cancer drug Rituxan receives federal approval to treat rheumatoid ... Mar 1, 2006
    San Jose Mercury News, The Food and Drug Administration action comes more than eight years after the agency initially approved Rituxan to treat non-Hodgkin's lymphoma. ...

    Stocks seen higher after steep fall Mar 1, 2006
    Washington Post, ...will be in focus as both companies said US regulators had approved their non-Hodgkin's lymphoma drug Rituxan as a treatment for rheumatoid arthritis. ...

    New use for cancer drug OK'd Mar 1, 2006
    Seattle Post Intelligencer Biogen Idec said. The drug, administered intravenously, was approved eight years ago to treat non-Hodgkin's lymphoma. Rituxan yielded ...

    US stocks seen higher after steep fall Mar 1, 2006
    Reuters.uk, ...(BIIB.O: Quote, Profile, Research) will be in focus as both companies said US regulators had approved their non-Hodgkin's lymphoma drug Rituxan as a treatment ...

    Omega-3 Flounders as Cancer Protection 25 Jan 2006
    CNN ...cell carcinoma of the oral cavity or pharynx, esophagus, or larynx); or other malignancies, such as bladder, lung, non-Hodgkin's lymphoma, ovarian, pancreatic ...

    I'VE HAD TERRIBLE INSULTS ABOUT MY HAIR ..WHAT IF I REALLY DID ... 25 Jan 2006
    Mirror.co.uk, ..."When they told me Alice was going to get Non-Hodgkin's Lymphoma - a type of leukaemia - I wanted to do my best to be true to people's experiences," she says. ...

    Genentech Share Price Currently A 'Good Entry Point' 25 Jan 2006
    Forbes ...as “a number of potential new indicationsâ€? for Genentech’s colorectal cancer drug, Avastin, as well as for Rituxan, a treatment for non-Hodgkin's lymphoma ...

    Trubion Names Michelle Burris Senior Vice President and CFO 25 Jan 2006
    Yahoo! News (press release) ...where she participated in the development and approval of Bexxar®, an antibody drug approved for the treatment of non-Hodgkin's lymphoma, the negotiation of ...

    Barbara J. Forsterling 25 Jan 2006
    Sheboygan Press, Barbara J. Forsterling, 56, of 1720 N. 11 St., died Saturday evening, January 21, 2006 at her home after a twelve-year battle with Hodgkin's Lymphoma. ...

    Subcutaneous Genasense(R) Trial Initiated in Patients with Solid ... 25 Jan 2006
    PR Newswire (press release), However, a prolonged subcutaneous infusion method using the existing IV formulation was studied in patients with advanced non-Hodgkin's lymphoma, which showed ...

    MedPanel Launches Profiles in Non-Hodgkin's Lymphoma -- United ... Jan 12, 2006
    Yahoo! News (press release) 12 /PRNewswire/ -- MedPanel, a leader in online medical market intelligence, announces the launch of Profiles in Non-Hodgkin's Lymphoma -- United States & ...

    Non-Hodgkin's lymphoma risk increased with prolonged high HIV ... Jan 10, 2006
    Aidsmap, Prolonged high HIV viral loads are associated with an increased risk of non-Hodgkin's lymphoma (NHL) independent of CD4 cell counts, according to data from the ...

    BiovaxID(TM) Yields 89% Survival in Patients with Aggressive Non ... Jan 24, 2006
    Genetic Engineering News, In this single-arm, open-label Phase 2 clinical study, patients with untreated mantle cell non-Hodgkin's lymphoma (NHL) were administered six cycles of dose ...

    Readers are wonderful Jan 23, 2006
    ic Coventry, Coventry. Mr Healy, a victim of the condition Hodgkin's Lymphoma, relied on the car, a Rover 100, to get to hospital for appointments. ...

    Fixture on the court: Bud Epplett's spirit, generosity at YMCA was ... Jan 23, 2006
    The Register-Guard, YMCA, where most players range from teenagers to men in their 50s - a court where Bud played until about two months before his death of non-Hodgkin's lymphoma. ...

    Be your own health-care advocate Jan 24, 2006
    Indianapolis Star, Medicine and How You Can, Too" (DaCapo Press, $25), Stephen H. Schneider uses his own successful battle against a rare form of non-Hodgkin's lymphoma as a ...

    LRAPA's new head is an old hand Jan 22, 2006
    The Register-Guard, He ran in memory of his older brother, Larry, who died of Hodgkin's lymphoma in 1992, and of a longtime DEQ co-worker, Spence Erickson, who died in August of ...

    MDS Pharma Services Named Preferred Contract Research Organization ... Jan 23, 2006
    PharmaLive.com (press release), An incurable but treatable disease, multiple myeloma is a cancer of the plasma cell and the second most prevalent blood cancer after non-Hodgkin's lymphoma. ...

    BiovaxID, Personalized Anti-Cancer Vaccine from Biovest ... Jan 10, 2006
    PharmaLive.com (press release), In this single-arm, Phase 2 study, patients with follicular B-cell Non-Hodgkin's Lymphoma (NHL) in continuous first clinical remission six months following ...

    Sick body, STRONG WILL Jan 21, 2006
    Miami Herald, ...college dropout, a pawnbroker who used to go to work with a .45-caliber pistol tucked in his belt, and a cancer patient diagnosed at 23 with Hodgkin's lymphoma ...

    He's a Gambler, and He's a Survivor Jan 23, 2006
    WBAY, ...said. Andrew was diagnosed with Hodgkin's lymphoma. Only 10 to 15 percent of all Hodgkin's cases are diagnosed in children under 16. ...

    ZEVALIN® Radioimmunotherapy May Play Greater Role In Combination ... Dec 27, 2005
    Medical News Today (press release), ...in refractory and hard-to-treat cancers, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular non-Hodgkin's lymphoma (FL ...

    Human Genome Sciences Reports on Progress Toward Commercialization ... Jan 10, 2006
    PR Newswire (press release), HGS-ETR1 is also moving forward. Our Phase 2 trial of HGS-ETR1 as monotherapy produced clinical responses in patients with non-Hodgkin's lymphoma. ...

    Favrille lymphoma drug fast tracked Jan 12, 2006
    United Press International SAN DIEGO, Jan. 12 (UPI) -- Favrille said Thursday it has received fast-track status for its non-Hodgkin's lymphoma drug FavId. ...

    FDA Adds new Cancer Warning to Eczema Cream and Ointment Labels ... Jan 19, 2006
    Best Syndication, According to L&S, users should watch for T-Cell Lymphom, Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), Hodgkin's Lymphoma (HL), Non-Hodgkin's ...

    Wheel theft means I can't get to hospital Jan 17, 2006
    ic Coventry, The 51-year-old, who lives with his 53-year-old wife Mary, has been battling Hodgkin's Lymphoma for five years and has to go to hospital for check-ups and ...

    In Sudan, faith guides their work Jan 21, 2006
    Milwaukee Journal Sentinel (subscription), ...served in a part of Vietnam where the toxic defoliant Agent Orange was used, Dennis Klepp, 54, has been battling cancer - non-Hodgkin's lymphoma - for about 15 ...

    Cytokinetics Raising $33M For Clinic, Corporate Uses Jan 18, 2006
    BioWorld Online (subscription), In September, Cytokinetics restructured the deal to take the lead in evaluating SB-743921 in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma ...

    Accentia says cancer vaccine encouraging in trial Jan 10, 2006
    Reuters ...(ABPI.O: Quote, Profile, Research) said on Tuesday that its experimental cancer vaccine appeared to help patients whose non-Hodgkin's lymphoma was in remission ...

    Favrille to Present at Brean Murray, Carret & Co. Small Cap ... Jan 18, 2006
    PharmaLive.com (press release), Dr. Gold will provide an overview of the Company and the clinical trials of its lead compound, FavId, for the treatment of B-cell non-Hodgkin's lymphoma (NHL). ...

    NHL Vaccine Encouraging in Trial Jan 11, 2006
    Cancerpage.com, NEW YORK JAN 10, 2006 (Reuters) - An experimental vaccine appears to help non-Hodgkin's lymphoma (NHL) patients who are in remission to remain in remission ...

    BioCryst Receives FDA Fast Track Designation for Peramivir Jan 17, 2006
    Biotech Intelligence (press release), Fodosine(TM) has been granted Orphan Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL ...

    Favrille Receives FDA Fast Track Designation for FavId, Lead ... Jan 12, 2006
    Yahoo! News (press release) FDA) has granted Fast Track designation for FavId®, the Company's lead product candidate for the treatment of B-cell follicular non-Hodgkin's lymphoma (NHL). ...

    Cancer no match for Athenas' Edgmon Jan 18, 2006
    Inland Valley Daily Bulletin, More specifically, it was Hodgkin's Lymphoma, or Hodgkin's disease, a cancer in the lymphatic tissue that has a lot to do with the body's immune and blood ...

    From the streets of NY to the halls of Mercy Jan 3, 2006
    Miami Herald, A tumor on his right wrist, suspicious marks on his left shoulder and back, a lump in his left breast led to diagnoses of non-Hodgkin's lymphoma and breast ...

    Favrille drug gets fast track designation Jan 12, 2006
    Reuters NEW YORK, Jan 12 (Reuters) - Favrille Inc. (FVRL.O: Quote, Profile, Research) on Thursday said its treatment for a type of non-Hodgkin's lymphoma had received ...

    Accentia Stock Rises on Study Results Jan 10, 2006
    MSN Money The mid-stage trial included patients with a type of non-Hodgkin's Lymphoma, a cancer of the immune system, who had been in remission following chemotherapy. ...

    UPDATE 1-Favrille drug gets fast track, shares jump 33 pct Jan 12, 2006
    Reuters ...(FVRL.O: Quote, Profile, Research) on Thursday said its vaccine treatment for a type of non-Hodgkin's lymphoma had received fast-track designation from the US ...

    Detroit chosen to ride first wave of HD radio Jan 19, 2006
    DetNews.com, WRIF-FM (101.1) continues to support Sabrina Black , the wife of 'RIF weekend jock Steve Black , in her battle with Hodgkin's Lymphoma. ...

    Dendreon lays off 34 as CFO departs Jan 21, 2006
    Seattle Post Intelligencer ...financial officer, she is known in the Seattle biotechnology industry for helping to win federal approval of Bexxar, a treatment for non-Hodgkin's lymphoma. ...

    Favrille cancer product receives fast track status Jan 13, 2006
    Pharmaceutical Business Review FavId, an investigational treatment for non-Hodgkin's lymphoma produced by biotech company Favrille, has been granted fast track designation by the FDA. ...

    CancerVax, Micromet Enter $127M Merger Agreement Jan 9, 2006
    BioWorld Online (subscription), ...cancer products in clinical development: MT201 in Phase II trials for metastatic breast and prostate cancers, and MT103 in Phase I for non-Hodgkin's lymphoma. ...

    MedPanel Adds New Oncology Study Jan 13, 2006
    Daily Research News Online, The new study – focusing on the increasingly common disease of non-Hodgkin's lymphoma – will evaluate clinical and market opportunities for treatments ...

    Hopes dashed for peanut allergy drug Xolair Jan 18, 2006
    News-Medical.net, Genentech's top-selling products are Rituxan, a treatment for non-Hodgkin's lymphoma and Avastin, a treatment for colorectal cancer.

    Health Notes Jan 21, 2006
    Hartford Courant, Dr. Rajani Nadkarni will give a free talk on non-Hodgkin's lymphoma Wednesday from 5:30 to 8 pm in the Horwitz Conference Center at MidState Medical Center. ...

    Pain doctor loses license, but gets no jail time Jan 20, 2006
    Roanoke Times, Boone was acquitted. A few months later, Knox and Boone were indicted a second time, but Knox's battle with non-Hodgkin's lymphoma delayed the trial. ...

    Stem cell research debated Jan 20, 2006
    Park Hills Daily Journal, She was in remission after having been treated for Hodgkin's Lymphoma. “They harvested my own healthy stem cells and froze them,â€? she said. ...

    When your child has cancer Jan 18, 2006
    Press & Sun-Bulletin, Regina Fields, a single mother from Cincinnati, agreed to participate in the film after her son, Al, was diagnosed with non-Hodgkin's lymphoma at age 11. ...

    Local blood donations exceed Ben's need Jan 18, 2006
    Long Beach Press-Telegram, Last June, doctors diagnosed Ben with non-Hodgkin's lymphoma after finding a pancake-sized tumor on the left side of his chest, pushing against his heart. ...

    Off-Label Use of Blood Clotting Drug, NovoSeven, Linked to Deaths ... Jan 19, 2006
    Newsinferno.com, ...the case. The US Food and Drug Administration approved Rituxan in 1997 as a treatment for a type of non-Hodgkin's lymphoma. US sales ...

    A War's Unwelcome Vestiges Jan 17, 2006
    TheDay (subscription), Orange. In February 2005, Sorensen was diagnosed with non-Hodgkin's lymphoma. Last September, the VA approved compensation for him. ...

    Wright consultant Bashis is back on Oakton Board Jan 19, 2006
    Pioneer Press Online, ...confidence.". Handzel, 72, was elected to the board in April 2001. He died Nov. 28 after losing a long battle with non-Hodgkin's lymphoma.

    Public plea to say prayer for families Jan 16, 2006
    Akron Beacon Journal, ...``About 18 months ago, I was diagnosed with Stage 4 non-Hodgkin's lymphoma. ... When he was 23, Dan Dean was diagnosed with non-Hodgkin's lymphoma. ...

    Christensen to run in marathon Jan. 8 Jan 6, 2006
    Farmington Valley Post, ...upcoming marathon in honor of two local residents, John Ferguson, a resident of New Hartford who recently passed away from non-Hodgkin's lymphoma, and Amanda ...

    Roanoke doctor stripped of right to practice Jan 20, 2006
    WVEC.com (subscription), The ordeal is finally behind me," said Knox, whose second trial was delayed while he battled non-Hodgkin's lymphoma, "but it is not finished for the patients.". ...

    Biovest International Announces Addition to Senior Management Team Jan 4, 2006
    Genetic Engineering News, ...a senior management team that is focused on the evaluation and commercial launch of BiovaxID(TM) for the treatment of indolent follicular non-Hodgkin's lymphoma ...

    Lively still living life to its fullest Jan 15, 2006
    Enterprise-Record, He left because "he didn't feel right.". He was later diagnosed with cancer, specifically Hodgkin's lymphoma, or Hodgkin's disease, in the winter of 1990. ...

    Launch new year with nutrition Jan 12, 2006
    Choteau Acantha, ...seven women; cancer of the uterus, 14 women; ovarian cancer, five women; cancer of the pancreas, five men and four women; non-Hodgkin's lymphoma and Hodgkin's ...

    UPDATE 1-Cancer drug sales lift Genentech quarterly profit Jan 10, 2006
    Reuters US sales of breast cancer treatment Herceptin jumped 98 percent to $250.1 million, while US sales of Rituxan for non-hodgkin's lymphoma rose 13 percent from a ...

    Genentech Says 4th-Qtr Profit Climbs on Cancer Drug Sales Jan 10, 2006
    Bloomberg Sales of Avastin have surpassed all of Genentech's other treatments except Rituxan, which is used against the blood cancer non-Hodgkin's lymphoma. ...

    Stevie Wonderboy might have legs to break the jinx Jan 14, 2006
    San Diego Union Tribune, Diagnosed late last year with non-Hodgkin's lymphoma, Dennis O'Neill is partway through a series of six chemotherapy treatments. ...

    More Upside Expected From Genentech Jan 10, 2006
    TheStreet.com Rituxan is expected to gain two new indications in first line non-Hodgkin's lymphoma and rheumatoid arthritis during the first quarter of 2006, and seems to ...

    Cancer drug sales lift Genentech quarterly profit Jan 10, 2006
    Reuters But US sales of Rituxan for non-Hodgkin's lymphoma also disappointed Wall Street as they rose 13 percent from a year earlier to $484.4 million. ...

    Genentech's 4Q earnings meet expectations Jan 10, 2006
    Seattle Post Intelligencer Genentech's recent prosperity largely stems from sales of its flagship product, the non-Hodgkin's lymphoma drug Rituxan, and a relative newcomer called Avastin ...

    Genentech income rises 64% in quarter Jan 11, 2006
    San Jose Mercury News, ...drugs. Rituxan, which the FDA approved in 1997 for treating non-Hodgkin's lymphoma, generated $1.8 billion in US sales last year. ...

    Genentech Announces Full Year and Fourth Quarter 2005 Results Jan 10, 2006
    MSN Money ...and Drug Administration (FDA) action on two Rituxan filings, one for front-line intermediate grade or aggressive front-line non-Hodgkin's lymphoma (NHL) and ...

    Favrille gets FDA FavId fast track Jan 12, 2006
    BusinessWeek Favrille is testing the treatment following Rituxan for patients with follicular B-cell non-Hodgkin's lymphoma, a cancer of the immune system. ...

    Fast-Track Frenzy Fires Up Favrille Jan 12, 2006
    TheStreet.com ...said the Food and Drug Administration granted fast-track designation to FavId, its lead product candidate for B-cell follicular non-Hodgkin's lymphoma. ...

    O'Neill Takes the Bad With the Good Jan 15, 2006
    Los Angeles Times, Stakes. The bad days are from the chemotherapy Dennis began three weeks ago after learning in December he has non-Hodgkin's lymphoma. ...

    San Rafael starts road to Kentucky Jan 13, 2006
    Los Angeles Daily News, ...for discovering Stevie Wonderboy at a Florida auction in February 2005, has begun chemotherapy after being diagnosed with non-Hodgkin's lymphoma last month. ...

    Genentech: An expensive darling Jan 9, 2006
    CNN/Money ...a breast cancer treatment for patients with a specific gene; Avastin, a treatment for colorectal cancer; and Rituxan, a treatment for non-Hodgkin's lymphoma. ...

    (PRN) - First Financial Holdings, Inc. Announces First Quarter ... Jan 12, 2006
    Bolsamania.com, No. 1 Hourly Worker ... [+. PRN) - MedPanel Launches Profiles in Non-Hodgkin's Lymphoma -- United States & Europe ... [+. PRN) - Pediatric ...

    Genentech's Shares Fall On Disappointing Avastin Sales Jan 11, 2006
    BioWorld Online (subscription), ...and Cambridge, Mass.-based Biogen Idec, and approved for non-Hodgkin's lymphoma (NHL), though the companies have filed an sBLA to win FDA approval for the drug ...

    Genentech's Q4 profit jumps 64%, but shares slip Jan 11, 2006
    Pharma Times (subscription), The company's flagship drug, Rituxan (rituximab), which is used to treat non-Hodgkin's lymphoma, racked up sales of $484 million for the period, rising 13 ...

    Alarm frontman diagnosed with leukemia Dec 29, 2005
    RTE.ie, He was previously diagnosed with Non-Hodgkin's Lymphoma - a cancer which has links with CLL. He has been in remission for almost ten years. ...

    Former worker sues Genentech over drug marketing Jan 11, 2006
    Eyewitness News, The FDA approved Rituxan in 1997 as a treatment for a type of non-Hodgkin's lymphoma. Studies have shown Rituxan may also help treat rheumatoid arthritis.

    Epstein - Barr virus Protein Implicated in Blood Cancer Dec 24, 2005
    MedIndia, Epstein-Barr virus is already implicated in diseases such as AIDS, Burkitt's lymphoma, Hodgkin's lymphoma, and nasopharyngeal carcinoma. ...

    Genelabs suffers setback on lupus drug Jan 16, 2006
    Pharma Times (subscription), ...sufferers of the disorder lies with Genetech/Biogen Idec's cancer drug Rituxan (rituximab), which is already on the market for non-Hodgkin's lymphoma but has ...

    CVP Plus Rituxan® Provides Long-Term Benefits in Patients with ... Dec 29, 2005
    Cancer Consultants (press release), Mabthera (Rituximab) Plus CVP Chemotherapy for First-Line Treatment of Stage III/IV Follicular Non-Hodgkin's Lymphoma (NHL): Confirmed Efficacy with Longer ...

    Deadline approaches for Appleby Jan 9, 2006
    St. Louis Post-Dispatch, In March 2005, the Blues announced that Don Granato, then the coach of the Worcester IceCats, had been diagnosed with Hodgkin's lymphoma. ...

    CancerVax to merge with German firm Jan 10, 2006
    North County Times, ...developing Canvaxin. The other drug, MT103, is in Phase I testing for safety in treating the B cell variety of non-Hodgkin's lymphoma. It ...

    Genentech/Biogen Idec: wearing the drug marketing suit well? Jan 12, 2006
    Pharmaceutical Business Review To date, Rituxan (rituximab) has only been approved by the FDA for non-Hodgkin's lymphoma, but doctors are already prescribing it for other cancer types. ...

    Former Phila. hospital exec dies Jan 5, 2006
    Philadelphia Business Journal, ...president and CEO of Main Line Health, died Wednesday morning at Thomas Jefferson University Hospital from complications related to non-Hodgkin's Lymphoma. ...

    Mechanism For Epstein-Barr Virus Protein's Role In Blood Cancers ... Dec 25, 2005
    Medical News Today (press release), ...plays a role in cancers such as lymphoproliferative diseases in transplant or AIDS patients, Burkitt's lymphoma, Hodgkin's lymphoma, and nasopharyngeal ...

    Koivu the conqueror Jan 11, 2006
    Denver Post, On Sept. 5, 2001, Koivu overnight had to go from trying to beat opposing goalies to battling non- Hodgkin's lymphoma. The cancer appears to have lost. ...

    Genentech said to halt allergy tests Jan 16, 2006
    CNN/Money The biotech's top-selling products are Rituxan, a treatment for non-Hodgkin's lymphoma that totaled $1.8 billion in US sales in 2005, and Avastin, a treatment ...

    Millennium Details Strategic Drivers for Profitable Growth and ... Jan 5, 2006
    PR Newswire (press release), ...a phase III study of VELCADE based therapy in patients with relapsed follicular lymphoma, an indolent form of non-Hodgkin's lymphoma Pipeline Millennium will ...

    ZymoGenetics Reports Preliminary Positive Results From TACI-Ig ... Jan 10, 2006
    PR Newswire (press release), ...studies in patients with SLE, rheumatoid arthritis and advanced B-cell malignancies, such as multiple myeloma, B-cell non-Hodgkin's lymphoma and chronic ...

    Hot Stocks: BWA MTG CRY FVRL SEBL RELL APOL MGA JAH -2- Jan 12, 2006
    New Ratings FAVRILLE INC (FVRL) Received fast-track designation from the Food and Drug Administration for its lead drug to treat a form of non-Hodgkin's lymphoma. ...

    IRS volunteer brings Arizona homeless many happy returns Jan 16, 2006
    Arizona Republic, ..."It allows them to start over. "In May of 2004, I was diagnosed with non-Hodgkin's lymphoma, and I've spent a lot of time in chemotherapy," he said. ...

    Former Steelheads owner talking stock Jan 15, 2006
    TheReporter.com, ...family. Portner celebrated an important anniversary on Jan. 3 - one year since he was first diagnosed with Hodgkin's Lymphoma. "I ...

    Fundraiser Helps Mother Lode Woman Fight Cancer Jan 8, 2006
    MyMotherLode.com, ...$10,000 was raised Friday night. 36-year-old Amy Gast was diagnosed with non-Hodgkin's Lymphoma in January 2004. Her sister in law ...

    The biotech blues Dec 29, 2005
    TheReporter.com, ...company, which was dubbed a global leader in manufacturing proteins and vaccines from tobacco plants in the fight against non-Hodgkin's lymphoma, cancers and ...

    Skating on thin ice Dec 29, 2005
    Baltimore Messenger, ..."I started typing words under Google to figure out what we were dealing with," he says. It's between aB cell and a Hodgkin's lymphoma. ...

    Cold Springs Woman In Need Of Cancer Treatment Funds Jan 3, 2006
    MyMotherLode.com, ...in her fight against cancer. 36-year-old Amy Gast was diagnosed with non-Hodgkin's Lymphoma in January 2004. Her sister in law, Wendy ...

    Overeating and Underactivity Increase Non-Hodgkin's Lymphoma Risk 21 Dec 2005
    Medscape (subscription) NEW YORK (Reuters Health) Dec 21 - People who overeat or who aren't physically active face a higher risk of non-Hodgkin's lymphoma (NHL), according to a report ...

    Patients with Unfavorable Risk Hodgkin’s Lymphoma May Not ... 21 Dec 2005
    Cancer Consultants (press release), Hodgkin's lymphoma is a cancer of the lymph system. It is diagnosed when a characteristic cell (the Reed- Sternberg cell) is identified under a microscope. ...

    MS part of Cavuto's world 21 Dec 2005
    USA Today Fox News anchor Neil Cavuto had already survived a near-fatal bout with Hodgkin's lymphoma when he suddenly started to suffer episodes of blindness, tingling ...

    PCB, Furan Exposure Increases Risk of Non-Hodgkin's Lymphoma Dec 15, 2005
    Cancerpage.com, NEW YORK DEC 14, 2005 (Reuters Health) - Exposure to polychlorinated biphenyls (PCBs) and furans may increase the risk of non-Hodgkin's lymphoma, according to ...

    Investigational Targeted Therapy May Offer Progress for Non ... Dec 10, 2005
    PR Newswire (press release), ...today offer evidence that an investigational targeted therapy may be useful in treating patients with the most common form of non-Hodgkin's lymphoma (NHL). ...

    Age Makes Little Difference in Outcomes for Non-Hodgkin's Lymphoma ... Dec 12, 2005
    DG News Older patients appear to achieve results on a par with their younger counterparts when they are treated with high-dose chemotherapy for Non-Hodgkin's lymphoma. ...

    Enzastaurin May Slow Progression of Non-Hodgkin's Lymphoma ... Dec 13, 2005
    DG News ...lymphoma. Non-Hodgkin's lymphoma makes up more than 80% of lymphomas, and is the sixth most common malignancy in the United States. ...

    (PRN) Tanox Submits Investigational New Drug Application for TNX ... Dec 20, 2005
    Houston Chronicle, TNOX) has filed an Investigational New Drug application with the Food and Drug Administration for TNX-650 for the treatment of Hodgkin's lymphoma that is ...

    Heavy Antibiotic Use Tied to Increased Non-Hodgkin's Lymphoma Risk Nov 18, 2005
    Cancerpage.com, 2005 (Reuters Health) - A history of using antibiotics more than 10 times in childhood increases the likelihood of developing non-Hodgkin's lymphoma (NHL) by 80 ...

    ATLANTA -- Abstracts Presented at 2005 ASH Annual Meeting Reveal ... Dec 14, 2005
    dBusinessNews Atlanta (press release), ...in refractory and hard-to-treat cancers, including diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular non-Hodgkin's lymphoma (FL ...

    Drug duo: New hope in cancer fight Dec 18, 2005
    Macon Telegraph, Patty Holtz developed non-Hodgkin's lymphoma, a cancer of the lymph nodes, 15 years ago. Chemotherapy kept it in check for about eight years. ...

    Pharmacyclics' Stock Crushed After Failed Phase III Of Xcytrin Dec 19, 2005
    BioWorld Online (subscription), ...was well tolerated and had synergistic activity in patients with Rituxan (rituximab)-refractory low-grade and transformed non-Hodgkin's lymphoma; Phase II ...

    Human Genome Sciences Reports Results of Phase 2 Clinical Trial of ... Dec 12, 2005
    Yahoo! News (press release) ...mapatumumab) is well tolerated and capable of producing clinical responses when administered as monotherapy in patients with advanced non-Hodgkin's lymphoma. ...

    A perfect plan Dec 18, 2005
    News-Leader.com, Three months pregnant, Melissa learned she had Hodgkin's lymphoma. The cancer would not spread to the placenta; the baby would be safe. ...

    A 'Village' with strong foundations Dec 14, 2005
    Lexington Winchester Star, Family is an important element of the holiday season, and when Shannon Haasis succumbed to an eight-year battle with Hodgkin's Lymphoma in March 2004, her ...

    PDX Shows Promising Activity in Patients With Resistant T-Cell ... Dec 12, 2005
    PR Newswire (press release), ...(Nasdaq: ALTH) today announced the presentation of interim results from an ongoing Phase 1/2 trial of PDX (pralatrexate) in patients with non-Hodgkin's Lymphoma ...

    Human Genome Sciences Reports Results of Phase 2 Clinical Trial of ... Dec 12, 2005
    PR Newswire (press release), ...- Clinical Responses Observed With Single-Agent HGS-ETR1 Administration In Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma - - Results Support ...

    New Data Suggest GM-CSF May Enhance Efficacy of Rituximab in ... Dec 12, 2005
    PR Newswire (press release), Follicular lymphoma is a common type of Non-Hodgkin's Lymphoma (NHL), making up about 25 percent of all cases of the incurable disease. ...

    Midland ignores public health? Dec 20, 2005
    The Saginaw News, ...cancer, four respiratory cancers, lymphocytic leukemia, multiple myeloma, peripheral neuropathy, Hodgkin's disease, non-Hodgkin's lymphoma, prostate cancer ...

    Phase II Study Demonstrates that ONTAK(R) Benefits Patients with ... Dec 14, 2005
    Business Wire (press release), Sheets:LGND) cancer drug ONTAK(R) (denileukin diftitox) benefits patients with relapsed/refractory T-cell and B-cell non-Hodgkin's lymphoma (NHL) according to ...

    Cougar Biotechnology Announces Presentation of Positive ... Dec 13, 2005
    Genetic Engineering News, ...preclinical experiments that demonstrate the effectiveness of the Company's drug CB3304 (noscapine) for the treatment of non-Hodgkin's lymphoma and multiple ...

    Zevalin Used in Abbreviated Chemotherapy Regimen Shows Efficacy ... Dec 16, 2005
    DG News Zevalin) and rituximab induces a high rate of clinical remission (CR/CRu) among patients with previously-untreated follicular non-Hodgkin's lymphoma (NHL). ...

    VELCADE(R) (bortezomib) for Injection Continues to Show Impressive ... Dec 12, 2005
    PR Newswire (press release), ...the results from phase II studies evaluating the efficacy and safety of VELCADE in patients with aggressive and indolent subtypes of non-Hodgkin's lymphoma (NHL ...

    MabThera Maintenance Therapy Dramatically Improves Survival for ... Dec 12, 2005
    CNW Telbec (Communiqués de presse), ...dramatically improves the chances of survival for patients suffering from one of the most frequent forms of lymphoma, indolent non-Hodgkin's Lymphoma (NHL). ...

    Seattle Genetics Reports SGN-40 Clinical Data at the American ... Dec 12, 2005
    Genetic Engineering News, Seattle Genetics, Inc. (Nasdaq: SGEN) reported data from its ongoing clinical trials of SGN-40 in multiple myeloma and non-Hodgkin's lymphoma at the American ...

    Seattle Genetics Reports SGN-40 Clinical Data at the American ... Dec 12, 2005
    PharmaLive.com (press release), ...(Nasdaq: SGEN) reported data from its ongoing clinical trials of SGN-40 in multiple myeloma and non-Hodgkin's lymphoma at the American Society of Hematology ...

    Total Body Irradiation Followed by Autologous Stem Cell ... Dec 13, 2005
    DG News ...by autologous stem cell transplantation appears to be the best option for patients with refractory chemo-resistant Hodgkin's lymphoma, researchers report. ...

    Cougar Biotechnology Announces Positive Interim Results from Phase ... Dec 12, 2005
    PharmaLive.com (press release), ...an orally active alkaloid that has been shown to induce conformational changes in tubulin, in patients with relapsed or refractory non-Hodgkin's lymphoma. ...

    Cephalon Oncology Reports High Response Rates to Single Agent ... Dec 12, 2005
    PR Newswire (press release), 12 /PRNewswire-FirstCall/ -- In a Phase 2 study of patients with advanced indolent non-Hodgkin's lymphoma (NHL) who were previously exposed to multiple courses ...

    Don’t take those swellings lightly Dec 8, 2005
    Deccan Herald, Lymphomas, categorised as Hodgkin Disease and Non-Hodgkin Lymphoma, has such discreet symptoms as painless swelling of the lymph nodes in neck, armpit or groin ...

    Cancer Care West developments mean brighter future for cancer ... Dec 15, 2005
    Galway Advertiser, Prior to radiotherapy being available, some of our patients with Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma had to travel to Dublin for ...

    Cancer drug tested here Dec 16, 2005
    Rochester Democrat and Chronicle, ...for a clinical trial on the effectiveness of bendamustine, a potential later-stage treatment for people with indolent non-Hodgkin's lymphoma, an incurable ...

    Chemotherapy Consolidation with Zevalin(R) (90Y-Ibritumomab ... Dec 12, 2005
    PR Newswire UK (press release), ...approval for Zevalin for the treatment of adult patients with rituximab relapsed or refractory CD20-positive follicular B-cell non-Hodgkin's lymphoma (NHL) in ...

    Investigative Drug Bendamustine (Treanda) Shows Notable Results ... Dec 12, 2005
    DG News ...agent (Treanda) has produced a therapeutic response in three quarters of patients with advanced, rituximab-refractory non-Hodgkin's lymphoma (NHL), researchers ...

    Genitope Corporation Files Patents For Personalized, Therapeutic ... Dec 8, 2005
    PR Newswire (press release), Antibodies Directed Against Specific Regions of the B-cell Receptor May Allow Targeting of Non-Hodgkin's Lymphoma Patient Subsets REDWOOD CITY, Calif., Dec. ...

    Cytokinetics Announces Selection of Development Candidate Directed ... Dec 13, 2005
    PR Newswire (press release), ...leading and funding development activities to explore the potential application of SB-743921 for the treatment of non-Hodgkin's lymphoma, Hodgkin's lymphoma ...

    Pharmacyclics Announces Presentation and Publication of ... Dec 12, 2005
    PR Newswire (press release), ...is well-tolerated and demonstrates synergistic activity in patients with Rituxan(R) (rituximab)-refractory low-grade and transformed non-Hodgkin's lymphoma (NHL ...

    Roche's MabThera dramatically improves survival for lymphoma ... Dec 12, 2005
    Forbes ...maintenance therapy with its MabThera drug 'dramatically improves' the chances of survival for patients suffering from indolent non-Hodgkin's Lymphoma (NHL), a ...

    Stem cells proving popular gift Dec 19, 2005
    CNN International Ahmed said the cells could be used in patients who had blood disorders, including blood cancers such as non-Hodgkin's lymphoma and leukemia, and some genetic ...

    HGS lymphoma drug stands out in studies Dec 12, 2005
    United Press International ATLANTA, Dec. 12 (UPI) -- Human Genome Sciences said Monday its Phase 2 study of HGS-ETR1 shows promise against advanced non-Hodgkin's lymphoma. ...

    FDG-PET Imaging in Addition to CT Imaging Could Help Determine ... Dec 14, 2005
    DG News ...analysis, Dr. Svoboda and his colleagues reviewed data on 19 patients with diffuse large B-cell lymphoma and 18 with Hodgkin's lymphoma, four with mantle cell ...

    Cephalon Oncology Reports High Response Rates to Single Agent ... Dec 12, 2005
    PharmaLive.com (press release), 12, 2005 /PRNewswire-FirstCall/ -- In a Phase 2 study of patients with advanced indolent non-Hodgkin's lymphoma (NHL) who were previously exposed to multiple ...

    Pesticide protection gets few takers Dec 18, 2005
    Danbury News Times, Others have been linked to human cancers, especially non-Hodgkin's lymphoma, one of the types of cancer that's rising most rapidly in the United States. ...

    Caring for the cured Dec 18, 2005
    Wisconsin State Journal, ...truth. Kristof's mother, Betsy Didrickson, remembers learning that the bulging lump on her son's neck was Hodgkin's lymphoma. Chemotherapy ...

    BioCryst Announces $30.0 Million Common Stock Offering to ... Dec 15, 2005
    PR Newswire (press release), Fodosine(TM) has been granted Orphan Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL ...

    Expert From The Leukemia & Lymphoma Society Available to Comment ... Dec 6, 2005
    PR Newswire (press release), This year emerging therapies for leukemia, non-Hodgkin's lymphoma, myeloma and myelodyplastic syndrome, will be among the significant findings being presented ...

    Phase II Clinical Results Indicate That MyVax Personalized ... Dec 12, 2005
    PharmaLive.com (press release), ...from a phase II clinical trial of Genitope Corporation's MyVax(R) Personalized Immunotherapy as a treatment for follicular Non- Hodgkin's Lymphoma (f-NHL ...

    AnorMED announces 73 percent of cancer patients who failed prior ... Dec 12, 2005
    PR Newswire (press release), ...the immune system of patients who have had chemotherapy to treat cancers of the immune system such as multiple myeloma and non-Hodgkin's lymphoma, among others ...

    Building Shannon's Village Dec 7, 2005
    Lexington Winchester Star, In 1995, at the age of 15, Winchester resident Jennifer Degnan's niece Shannon Haasis was diagnosed with Hodgkin's Lymphoma, a form of cancer. ...

    EarthLink agrees to buy New Edge Dec 14, 2005
    Seattle Times, ...of Hematology's annual meeting, concluded Tuesday, SGN-40 showed early signs of effect in its first human trials against non-Hodgkin's lymphoma and multiple ...

    Rifts and unions Dec 18, 2005
    The Mercury, Now settled in her relationship and in remission from Hodgkin's lymphoma, Goodrem fulfilled a lifelong ambition by performing at the MCG as her beloved Sydney ...

    As not seen on TV: Cancer survivors tell what to expect Dec 19, 2005
    Fort Worth Star Telegram, ...is flawed.". -- David H. Johnson, MD, deputy director of Vanderbilt-Ingram Cancer Center, non-Hodgkin's lymphoma survivor. "After I ...

    Web Extra: More workers are staying on the job while they fight ... Dec 19, 2005
    Asbury Park Press, When Bill Seman, 63, was diagnosed with non-Hodgkin's lymphoma, he initially thought about retiring and had a retirement plan drawn up that he kept in his desk ...

    Belton 12-year-old brings community together Dec 18, 2005
    KCEN-TV, ...cancer," she says. Twelve-year-old Tyler was diagnosed with leukemia and Hodgkin's lymphoma in December 2003. "Thursday is Tyler's ...

    Phase II Clinical Results Indicate That MyVax(R) Personalized ... Dec 12, 2005
    Yahoo! News (press release) ...clinical trial of Genitope Corporation's (Nasdaq: GTOP - News) MyVax® Personalized Immunotherapy as a treatment for follicular Non- Hodgkin's Lymphoma (f-NHL ...

    Amgen offers support Dec 18, 2005
    Ventura County Star (subscription), She talked about her own experience racing and breaking cycling records after receiving her diagnosis of non-Hodgkin's lymphoma. ...

    Scientific Advances on Three Lead Cephalon Oncology Compounds to ... Dec 8, 2005
    PR Newswire (press release), Multiple Phase 2 clinical trials suggest potential efficacy in indolent non-Hodgkin's lymphoma (NHL) refractory or relapsed from both traditional alkylators ...

    Cephalon expected to buy British drugmaker Dec 6, 2005
    philly.com, Salmedix's lead compound, Treanda, is in midstage Phase 2 clinical trials in the United States and Canada for non-Hodgkin's lymphoma, a blood cancer. ...

    Immunomedics Reports Humanized Anti-CD20 Antibody Appears Safe and ... Dec 12, 2005
    DG News ...reported initial response and safety results with the Company's humanized anti-CD20 (hA20) monoclonal antibody in patients with non-Hodgkin's lymphoma (NHL) at ...

    Genitope Corporation Files Patents For Personalized, Therapeutic ... Dec 8, 2005
    Biotech Intelligence (press release), The methods and materials described in these patents potentially represent a novel, personalized approach for treating non-Hodgkin's lymphoma (NHL). ...

    Accentia Biopharmaceuticals announces that follow-up data Dec 2, 2005
    EurekAlert (press release), In the Phase 3 trial patients with follicular B-cell non-Hodgkin's lymphoma are being treated with BiovaxID immunotherapy following PACE [Prednisone ...

    CVC coaches join fight vs. cancer Dec 15, 2005
    Trenton Times, Cancer," said Gazdek, who himself was diagnosed with Non-Hodgkin's Lymphoma in November 2003 and underwent successful treatment last year. ...

    Pro-Life Group Applauds Passage of Wisconsin Cord Blood Donation ... Dec 16, 2005
    Christian Post, ...conditions that can be treated with cord blood include certain types of leukemia, disorders such as Hodgkin's disease and non-Hodgkin's lymphoma, spinal cord ...

    AutovaxID(TM)-C Introduced by Accentia Biopharmaceuticals ... Dec 8, 2005
    Genetic Engineering News, Research. BiovaxID(TM) is a patient-specific anti-cancer vaccine intended for the treatment of follicular non-Hodgkin's lymphoma. ...

    Roche seeks wider use of top cancer drug MabThera Dec 12, 2005
    Reuters Profile, Research) has asked European regulators to allow wider use of its top-selling drug MabThera in the treatment of non-Hodgkin's Lymphoma, a cancer of ...

    Study on Paritutu cancer risk a whitewash - Greens Dec 11, 2005
    Stuff.co.nz, ...cancers, which have been associated with dioxin exposure, recorded very high incidences: there was a 75 per cent higher rate of non-Hodgkin's lymphoma (33 cases ...

    Immunomedics Reports Updated Clinical Results of Epratuzmab ... Dec 9, 2005
    PR Newswire (press release), ...the safety and response rates of its lead product, epratuzumab, in combination with rituximab in the treatment of patients with non-Hodgkin's lymphoma (NHL). ...

    Combo therapy effective for NHL Dec 15, 2005
    myDNA.com, A new trial looking at patients with follicular B-cell non-Hodgkin's lymphoma (NHL) finds that the drug Rituxan (rituximab), followed by a vaccination with an ...

    Family seeks justice for Julie Dec 17, 2005
    Brockton Enterprise, ...husband. Her husband, Walter Adams, was battling Hodgkin's lymphoma when Julie was struck, and his condition began deteriorating. ...

    OHS girls hoops: Struggles continue with losses to Mauston, Tomah Dec 16, 2005
    Onalaska Life, McIlquham, 42, a teacher and coach at Onalaska since 1993, was also diagnosed with Hodgkin's Lymphoma in May of 2001. “We played hard,â€? Vieaux said. ...

    Human Genome Sciences Announces Decision to Spin Off CoGenesys ... Dec 13, 2005
    PR Newswire (press release), ...the treatment of chronic hepatitis C; and HGS-ETR1 (mapatumumab) for the treatment of non-small cell lung cancer, colorectal cancer and non-Hodgkin's lymphoma. ...

    Cougar Biotechnology Announces Initiation of Phase I/II Trial for ... Dec 14, 2005
    Genetic Engineering News, ...which has completed Phase I clinical trials in prostate cancer, CB3304, which is currently being tested in a Phase I trial in non-Hodgkin's lymphoma and CB1089 ...

    : New York Times Whitewashes Environmental Causes of Cancer Dec 14, 2005
    NewsReleaseWire.com (press release) These include: Non-Hodgkin's lymphoma, by 74%; acute childhood leukemia, by 68%; childhood brain cancer, by 52%; acute adult leukemia, by 56%; and testes cancer ...

    New York Times Whitewashes Environmental Causes of Cancer -- by ... Dec 14, 2005
    AScribe These include: Non-Hodgkin's lymphoma, by 74 percent; acute childhood leukemia, by 68 percent; childhood brain cancer, by 52 percent; acute adult leukemia, by ...

    ASH: Experimental Chemotherapy Drug Effective Against Resistant ... Dec 14, 2005
    MedPage Today, ...appears effective at producing durable objective responses in heavily pre-treated patients with indolent non-Hodgkin's lymphoma (NHL), researchers here reported ...

    Geoff Oldfather: Martin County woman enters race to fight cancer Dec 10, 2005
    Stuart News (subscription), 8. She plans to raise a lot more. Her husband Matt Brewi, 58, has been battling Non-Hodgkin's Lymphoma for more than a year. He's ...

    ALBEE/MAPLE GROVE TOWNSHIPS Dec 15, 2005
    The Saginaw News, Saturday. Information, 770-4844. 1 pm to 6:30 pm Sunday will benefit Amber Newsome, 50, who is battling non-Hodgkin's lymphoma. The ...

    Ligand Pharmaceuticals presents new data Dec 15, 2005
    San Diego Daily Transcript (subscription), ...(Pink: LGND.PK, News) shows that the cancer drug Ontak benefits patients with relapsed/refractory T-cell and B-cell non-Hodgkin's lymphoma. ...

    Pharmacyclics Announces Presentation and Published Abstracts on ... Dec 6, 2005
    PR Newswire (press release), R); 90Yttrium-Zevalin) Radioimmunotherapy (RIT) Produces High Complete Remission Rates in Relapsed Rituximab-Refractory Follicular Non-Hodgkin's Lymphoma (NHL ...

    Freshman handling it well Dec 6, 2005
    Boston Globe, ...put into perspective after Randy Cave, his coach at LC Bird High, was diagnosed last month with Burkitt's lymphoma, a type of non-Hodgkin's lymphoma that most ...

    A fond farewell Dec 13, 2005
    Daily Pennsylvanian, ...column. After writing about my Dad's non-Hodgkin's Lymphoma, more than 100 people e-mailed me to get into the bone marrow database. ...

    MDS Reports Fourth Quarter and Fiscal 2005 Financial Results Dec 14, 2005
    Canada NewsWire (press release), ...by Berlex Canada to supply Yttrium-90 Chloride Sterile Solution (Y-90) for use with Berlex's ZEVALIN(R) radioimmunotherapy treatment for non-Hodgkin's lymphoma ...

    California researchers find a link between antibiotics and ... Dec 6, 2005
    Newstarget.com, Researchers have found the use of antibiotics more than 10 times during childhood increases the likelihood of developing non-Hodgkin's lymphoma (NHL), a cancer ...

    Association of Severe Mucocutaneous Reactions with the Zevalin ... Dec 12, 2005
    DG News ...indicated for the treatment of patients with relapsed or refractory low-grade or follicular, CD20 positive, B-cell non-Hodgkin's lymphoma, including patients ...

    Hodgkin’s Survivors: Increased Fatigue, Cardiac, and Thyroid ... Dec 2, 2005
    Cancer Consultants (press release), Hodgkin's lymphoma is a cancer of the lymph system, which is part of the immune (infection fighting) system; it includes blood vessels, bone marrow, lymph nodes ...

    Favrille Reports Positive Data from Phase 2 Clinical Trial of ... Dec 13, 2005
    PR Newswire (press release), ...follow-up data from its Phase 2 clinical trial of FavId(R) following Rituxan(R) treatment in patients with follicular B-cell non-Hodgkin's lymphoma (NHL) today ...

    Skyhawks coach Cave loses battle with cancer Dec 9, 2005
    Petersburg Progress Index, Cave died Tuesday at Medical College of Virginia after a short battle with Burkitt's lymphoma, a fast-spreading cancer classified as non-Hodgkin's lymphoma. ...

    Retrospective Analysis Finds EFAPROXYN(TM) Extends Survival With ... Dec 12, 2005
    PR Newswire (press release), ...under investigation as both a single agent and in combination therapy regimens in patients with non-small cell lung cancer and Non-Hodgkin's lymphoma; and RH1 ...

    CuraGen and TopoTarget Announce Presentation of PXD101 Phase I ... Dec 12, 2005
    PharmaLive.com (press release), ...tolerated following intravenous administration and has demonstrated potential anti-tumor activity against multiple myeloma, non-Hodgkin's lymphoma (NHL) and ...

    Favrille Announces Long-Term Follow-Up Data From Phase 2 Clinical ... Dec 7, 2005
    PharmaLive.com (press release), ...follow-up data from its Phase 2 clinical trial of FavId(R) following Rituxan(R) treatment in patients with follicular B-cell non-Hodgkin's lymphoma (NHL) will ...

    HuMax-CD20 Induces Rapid Responses in Relapsed CLL Patients Dec 12, 2005
    PR Newswire (press release), CLL is a subgroup of non-Hodgkin's lymphoma (NHL) and together with small lymphocytic lymphoma (SLL) corresponds to around 20% of all NHL cases. ...

    PHARMAMAR REPORTS POSITIVE PHASE II RESULTS ON APLIDIN(R) IN ... Dec 12, 2005
    ITNews, Phase II trials in progress which evaluate Aplidin in a number of other tumour types, including melanoma, solid tumours and Non-Hodgkin's Lymphoma, both as a ...

    Cancer survivor sees bright future Dec 5, 2005
    Arizona Republic, ...was stunned. What mass? The diagnosis: Non-Hodgkin's lymphoma had formed an orange-size tumor on her heart sac. In December, she ...

    CuraGen deal produces new cancer drug data Dec 13, 2005
    DrugResearcher.com, ...is well tolerated following intravenous administration demonstrating potential anti-tumour activity against multiple myeloma, non-Hodgkin's lymphoma (NHL) and ...

    Biovest International Announces that it will report new follow-up ... Dec 2, 2005
    EurekAlert (press release), In the Phase III trial, patients with follicular B-cell non-Hodgkin's lymphoma are being treated with BiovaxID immunotherapy following PACE [Prednisone ...

    New Data on VELCADE(R) (bortezomib) for Injection to Be Presented ... Dec 6, 2005
    PR Newswire (press release), 509) Across Lymphomas * VELCADE activity in studies in a variety of lymphomas -- Combination with rituximab in indolent non-Hodgkin's lymphoma (abstract #7 ...

    After courtship like theirs, marriage is a breeze 13 Nov 2005
    commercialappeal.com (subscription), In 2002 Wayman, who worked out regularly, was diagnosed with Hodgkin's lymphoma, a cancer of the lymph system. "It was devastating," says Melita. ...

    Autoimmune Disease Tied to Non-Hodgkin's Lymphoma Nov 1, 2005
    Cancerpage.com, ...with autoimmune disorders such as rheumatoid arthritis and Sjogren's syndrome appear to be at greater risk of non-Hodgkin's lymphoma (NHL), researchers report ...

    Doctors Can Halve Radiation Dose for Hodgkin's Lymphoma Oct 17, 2005
    Forbes News) -- Halving the usual dose of radiation and combining it with chemotherapy can produce high survival rates in people with early-stage Hodgkin's lymphoma. ...

    Hodgkin's vs. non-Hodgkin's lymphoma: What's the difference? Oct 28, 2005
    MayoClinic.com In Hodgkin's disease, also called Hodgkin's lymphoma, the abnormal cell involved is known as the Reed-Sternberg cell (B lymphocyte). ...

    WV firefighter praises legislation Nov 10, 2005
    Vancouver North Shore Outlook, ...year-old boys. "The studies have shown that non-Hodgkin's lymphoma can be caused from firefighter duties.". After battling cancer ...

    Tackling lymphoma Oct 29, 2005
    Daily News Journal (subscription), ..."It was hard because I had to be on TV in the middle of chemo (therapy)," says Hoge, who was diagnosed with non-Hodgkin's lymphoma, a cancer of the lymphatic ...

    Cancer drug trial results touted Nov 10, 2005
    Seattle Post Intelligencer ...drug to treat non-Hodgkin's lymphoma prolongs the time before a patient's symptoms progress, the Seattle biopharmaceutical company reported Wednesday. ...

    Addition of Pixantrone to Rituxan Therapy Significantly Prolongs ... Nov 9, 2005
    PharmaLive.com (press release), Rituxan plus pixantrone in 38 relapsed or refractory patients who had previously failed up to five prior treatments for indolent non-Hodgkin's lymphoma (NHL). ...

    Dendreon CFO takes over manufacturing Nov 11, 2005
    Seattle Post Intelligencer A Corixa employee for 10 years, she was a key executive in winning federal approval for Bexxar, a treatment for non-Hodgkin's lymphoma. ...

    Firefighters see compensation changes Nov 12, 2005
    Richmond Review, The cancers are primary site brain, bladder, kidney, colorectal and ureter cancer, primary non-Hodgkin's lymphoma and primary leukemia. ...

    Lymph-node cancers are treatable Nov 1, 2005
    Contra Costa Times, Q: Our family would like to know the differences among lymphoma, Hodgkin's disease and non-Hodgkin's lymphoma. A: Lymphoma is cancer ...

    GPC Biotech Announces Clearance From German Regulatory Authority ... Nov 9, 2005
    Market Wire (press release) ...it was estimated that more than 54,000 people in the US and about 64,000 people in the European Union were diagnosed with non-Hodgkin's lymphoma, the most ...

    Human Genome Sciences Reports Results of Phase 2 Clinical Trial of ... Nov 1, 2005
    Yahoo! News (press release) In June 2005, we reported the interim results of a Phase 2 study of this drug in patients with advanced non-Hodgkin's lymphoma, and we anticipate presentation ...

    Radiation, chemo cuts OK for lymphoma Oct 18, 2005
    Science Daily (press release) ...the amount of the body that receives radiation, and reducing the radiation dose by one-third still allows effective treatment for Hodgkin's lymphoma, a form of ...

    Review: Drinking-Water Nitrate and Health Nov 6, 2005
    Food Consumer, In Slovakia, incidence of non-Hodgkin lymphoma (NHL) and colon cancer was significantly elevated among men and women exposed to public supply nitrate levels of ...

    Amenorrhea Common After Hodgkin's Treatment Nov 10, 2005
    Cancerpage.com, Most women stop having their menstrual period, a condition called amenorrhea, after undergoing chemotherapy for advanced-stage Hodgkin's lymphoma (HL), cancer ...

    Viral links spur the search for cancer vaccines Nov 1, 2005
    The Financial Express, Current trials for therapeutic vaccines are targeting melanoma, kidney, lung and breast cancers, Hodgkin's and Non-Hodgkin's lymphoma, the NCI says. ...

    THIRD ACCIDENTAL DEATH AT KAISER PERMANENTE Nov 9, 2005
    CBS 5, ...wrong medication. Christopher Wibeto, who was diagnosed with non-Hodgkin's lymphoma, was given the wrong chemotherapy drug on Aug. 26 ...

    Genitope Corporation Announces Financial Results for Third Quarter ... Nov 8, 2005
    PR Newswire (press release), ...of our lead product candidate, MyVax(R) Personalized Immunotherapy, in patients with previously untreated follicular non-Hodgkin's lymphoma, is progressing as ...

    Millennium Announces Clinical Updates at Analyst Day Meeting Nov 2, 2005
    PR Newswire (press release), Non-Hodgkin's Lymphoma The Company announced today its intention to file a supplemental New Drug Application (sNDA) for VELCADE in mantle cell lymphoma in the ...

    Cancer patients get new drug before appraisal Nov 11, 2005
    Yorkshire Post Today, ...system. Evidence suggests the drug will double the re-mission time of patients diagnosed with follicular non-Hodgkin's lymphoma. ...

    Allos Therapeutics Reports Third Quarter 2005 Financial Results Nov 10, 2005
    PR Newswire (press release), ...under investigation as both a single agent and in combination therapy regimens in patients with non-small cell lung cancer and Non-Hodgkin's lymphoma; and RH1 ...

    Phase III MabThera maintenance trial in lymphoma shows positive ... Oct 30, 2005
    Medical News Today (press release), ...the European Organisation for Research and Treatment of Cancer (EORTC) that a phase III study[1] in relapsed indolent non-Hodgkin's lymphoma (NHL) evaluating ...

    British Columbia Recognizes Cancer as an Occupational Hazard for ... Nov 10, 2005
    Homeland Response, The types of cancer are primary site brain cancer, primary site bladder cancer, primary site kidney cancer, primary non-Hodgkin's lymphoma, primary site ureter ...

    Delta in the dark on 21st Nov 6, 2005
    Melbourne Herald Sun, ...accept the Celebrity Advocacy Award for her cancer research trust fund at Sydney's St Vincent's Hospital, where she was treated for Hodgkin's lymphoma in 2003. ...

    Cell hits treatment goals, but stock is sold Nov 11, 2005
    Seattle Times, Cell Therapeutics said it hit its treatment goals in a trial of pixantrone in patients with relapsed non-Hodgkin's lymphoma, but investors sold off the Seattle ...

    Devlin faces biggest test Nov 7, 2005
    The Wimmera Mail Times, Surgery and biopsy on the golf-ball-size lump at the end of the football season in September revealed he had Hodgkin's lymphoma, a cancer that attacks the ...

    Legendary Bearcat Cook dies Nov 9, 2005
    Cullman Times Online, St. Bernard Preparatory School. Cook coached the defense for the Saints, even though he was battling non-Hodgkin's lymphoma. "He ...

    CAROL CAIN / MACOMB: Not even illness could stop salon owner Nov 10, 2005
    Detroit Free Press, ...malaise a second thought. Ten years ago, Pniewski was diagnosed with non-Hodgkin's lymphoma. She underwent surgery, chemotherapy ...

    Officer, mother does it all Nov 10, 2005
    Asbury Park Press, ...the Manchester Little League field organizing a charity baseball game to raise money to help Derek Biederstadt, a local 14-year-old with non-Hodgkin's lymphoma ...

    FDA Approves Arranon to Treat Rare Leukemia and Lymphoma Nov 7, 2005
    AXcess News, T-ALL. Lymphoblastic lymphoma (LBL) represents approximately 30% of childhood and 3% of adult non-Hodgkin's lymphoma (NHL). An estimated ...

    Favrille to Expand Existing Facility to Support Commercial ... Nov 7, 2005
    PR Newswire (press release), ...of FavId(R), the Company's lead product candidate currently in a Phase 3 clinical trial for the treatment of follicular B-cell non-Hodgkin's lymphoma (NHL). ...

    Why We Can't Prevent Cancer Nov 4, 2005
    CounterPunch, ...by 690%, female lung & bronchial cancer increased by 685%, prostate cancer by 286%, myeloma by 273%, thyroid cancer by 258%, non-Hodgkin's lymphoma by 249 ...

    ASTRO: Doctors Can Halve Dose of Radiation and Still Cure ... Oct 17, 2005
    U.S. Newswire (press release), 17 /US Newswire/ -- Doctors in Germany have determined that patients suffering from early-stage Hodgkin's lymphoma can receive a reduced dose of involved field ...

    FDA Grants Priority Review for Rituxan(R) Supplemental Biologics ... Oct 25, 2005
    PR Newswire (press release), R) (Rituximab) in previously-untreated (front-line) patients with intermediate grade or aggressive, CD20-positive, B-cell, non-Hodgkin's lymphoma (NHL) in ...

    Yttrium 90 Ibritumomab Tiuxetan (Zevalin) as Effective in Older as ... Oct 24, 2005
    DG News ...that use of the radioimmunotherapy agent yttrium 90 ibritumomab tiuxetan (Zevalin) is at least as effective in treating non-Hodgkin's lymphoma in patients over ...

    FDA eyes wider use of Rituxan Oct 26, 2005
    Inside Bay Area, ...whether Rituxan should be used with chemotherapy as a first treatment for patients with intermediate or aggressive non-Hodgkin's lymphoma, the companies said. ...

    UK's CAT buys cancer drug candidates from Danisco Nov 1, 2005
    ABC News Phase II clinical trials for hairy cell leukemia (HCL), and GCR-8015, a preclinical treatment for cancers including non-Hodgkin's lymphoma, from Danisco's ...

    Structure of the Hematological Cancer Market and Its Perspectives Nov 3, 2005
    Business Wire (press release), ...at a multitude of small oncology companies for leukemias and myelodysplastic syndromes, lymphomas (Hodgkin's disease, non-Hodgkin's lymphoma, mantle cell ...

    Radiation, Chemotherapy Can Be Reduced Without Losing Efficacy in ... Oct 24, 2005
    DG News ...were able to dramatically reduce the radiation and chemotherapy doses without sacrificing efficacy in a study of more than 1100 patients with Hodgkin's lymphoma ...

    Doctors Can Halve Dose Of Radiation And Still Cure Hodgkin's Oct 20, 2005
    Science Daily (press release) Doctors in Germany have determined that patients suffering from early-stage Hodgkin's lymphoma can receive a reduced dose of involved field radiation therapy ...

    Genentech/Biogen cancer drug granted priority review by FDA Oct 27, 2005
    Pharmaceutical Business Review ...review to the license application submitted by Genentech and Biogen Idec for Rituxan as an adjunctive treatment for patients with non-Hodgkin's lymphoma. ...

    Richard E. Smalley, RIP Oct 29, 2005
    Scientific American E. Smalley, one of the co-discoverers of "buckyballs" and other fullerenes, died on Friday after years of intermittent struggle with non-Hodgkin's lymphoma. ...

    Delta's birthday wish Nov 7, 2005
    Daily Telegraph, ...from the Thank You Day committee for establishing her cancer research trust fund at St Vincent's Hospital, where she was treated for Hodgkin's lymphoma in 2003 ...

    FDA grants speedy review to Biogen, Genentech drug Oct 31, 2005
    Reuters ...(DNA.N: Quote, Profile, Research) on Monday said US regulators would review on a priority basis their application to sell a non-Hodgkin's lymphoma drug they co ...

    Children and researchers sing Goodrem's praises Nov 7, 2005
    The Age (subscription), ..."Hang in there and be positive. Have faith," said Goodrem, who was diagnosed with Hodgkin's lymphoma as an 18-year-old in 2003. ...

    Obesity linked with leukemia Nov 4, 2005
    Melbourne Herald Sun, ...the risk of myeloid leukemia was influenced by body size, the risk of multiple myeloma, lymphocytic leukemia, hairy cell leukemia, Hodgkin's lymphoma and non ...

    Local investors back Accentia IPO Nov 7, 2005
    MSNBC Accentia's second potential blockbuster is Biovaxid, an injectable vaccine for the treatment of follicular non-Hodgkin's lymphoma (NHL). ...

    FDA grants fast review to lymphoma drug Oct 25, 2005
    United Press International ...of the new therapy for previously untreated patients with intermediate grade or aggressive, CD20-positive, B cell non-Hodgkin's lymphoma, in combination with ...

    IOM Report Finds Doctors Ill-Equipped for Cancer Survivors Nov 9, 2005
    MedPage Today, For instance, according to the report 40% of women who survive Hodgkin's lymphoma don't realize they have an increased risk of breast cancer and just 22% of ...

    PRAECIS PHARMACEUTICALS INCORPORATED To Present at the Rodman & ... Nov 7, 2005
    Genetic Engineering News, PRAECIS has a novel MetAP-2 inhibitor, PPI-2458, in clinical development for non-Hodgkin's lymphoma and solid tumors, as well as an innovative drug discovery ...

    Versatile Rituxan gets arthritis review Nov 1, 2005
    Inside Bay Area, ...and Biogen Idec Inc.'s Rituxan, a cancer drug being considered for wider use against non-Hodgkin's lymphoma, has also won priority review as a treatment for ...

    Tanox Reports 2005 Third Quarter Results Nov 2, 2005
    PR Newswire (press release), Continuing development of several pre-clinical compounds, including TNX-650 as a potential treatment for Hodgkin's lymphoma, other cancer indications and ...

    A Cancer Win Not All Firefighters Share Nov 9, 2005
    TheTyee.ca, ...passed legislation forcing the WCB to recognize seven kinds of cancer (brain cancer, bladder cancer, kidney cancer, non-Hodgkin's lymphoma, ureter, leukemia ...

    Millennium Announces Clinical Updates at Analyst Day Meeting Nov 2, 2005
    Yahoo! News (press release) Management also announced completed enrollment of 81 patients in a phase II study of VELCADE in relapsed follicular lymphoma, a type of Non-Hodgkin's lymphoma. ...

    AnorMED reports fiscal 2006 second quarter results, and progress ... Nov 8, 2005
    PR Newswire (press release), To date, 98 non-Hodgkin's lymphoma (NHL) patients and 100 multiple myeloma (MM) patients have entered into the Phase III trials. ...

    FIREFIGHTERS: Compensation Volunteers excluded Nov 8, 2005
    Williams Lake Tribune, These are: primary site brain cancer, primary site bladder cancer, primary site kidney cancer, primary non-Hodgkin's lymphoma, primary site ureter cancer ...

    BioCryst to Present at the Rodman & Renshaw Techvest 7th Annual ... Nov 2, 2005
    Yahoo! News (press release) Fodosine(TM) has been granted Orphan Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL ...

    Biogen warns of drug's dangers Oct 29, 2005
    San Diego Union Tribune, Biogen Idec warned that one of its drugs to treat non-Hodgkin's lymphoma, Zevalin, can cause severe and sometimes fatal skin reactions. ...

    Wife: please help ease my husband's suffering Nov 9, 2005
    Bexley Times, The 34-year-old's plea comes four years after her husband Somir, 44, was diagnosed with non-Hodgkin's Lymphoma, a cancer of the muscle tissue. ...

    Risk of Second Cancers After Hodgkin’s Lymphoma Is Similar ... Nov 2, 2005
    Cancer Consultants (press release), Hodgkin's lymphoma is a cancer of the lymph system. It is diagnosed by identifying a characteristic cell under the microscope (the Reed-Sternberg cell). ...

    Cancer vaccine Nov 8, 2005
    WHDH-TV, ...customized vaccines. Tom Berthold was diagnosed in 1996 with non-Hodgkin's lymphoma… a cancer of the immune system. He underwent ...

    Favrille Reports Third Quarter 2005 Financial Results Nov 2, 2005
    PR Newswire (press release), ...product candidate, FavId(R), is nearing completion of patient enrollment in a pivotal Phase 3 clinical trial for follicular B-cell non-Hodgkin's lymphoma (NHL ...

    Richard E. Smalley, RIP Oct 30, 2005
    LaSalute.net, E. Smalley, one of the co-discoverers of "buckyballs" and other fullerenes, died on Friday after years of intermittent struggle with non-Hodgkin's lymphoma... ...

    Biogen Idec and Genentech Announce FDA Acceptance of Supplemental ... Oct 31, 2005
    PR Newswire (press release), ...received FDA approval in November 1997 for the treatment of relapsed or refractory low-grade or follicular, CD20-positive, B-cell, non-Hodgkin's lymphoma (NHL ...

    GlaxoSmithKline Announces Approval of ARRANON(R) (nelarabine) ... Oct 29, 2005
    Biotech Intelligence (press release), Lymphoblastic lymphoma (LBL) is a type of non-Hodgkin's lymphoma (NHL), a cancer of the lymphatic system, which occurs more often in children than adults. ...

    UPDATE 1-Genentech says FDA gives Rituxan priority review Oct 25, 2005
    Reuters ...said their cancer drug Rituxan will get a speedy review from US regulators for the treatment of aggressive, but previously untreated non-Hodgkin's lymphoma. ...

    Roche says Phase III trial of cancer drug MabThera yields positive ... Oct 25, 2005
    Forbes ...on trial by the European Organisation for Research and Treatment of Cancer as a treatment in so-called 'relapsed indolent non-Hodgkin's lymphoma' (NHL), is ...

    Cytokinetics, Incorporated Reports Third Quarter 2005 Financial ... Oct 26, 2005
    Yahoo! News (press release) ...will expand its role in clinical research and development and funding of SB-743921 for the indications of non-Hodgkin's lymphoma, Hodgkin's lymphoma and ...

    Surviving Childhood Hodgkin's Increases Stroke Risk Sharply Oct 14, 2005
    MedPage Today, DALLAS, Oct. 14 - Surviving Hodgkin's lymphoma in childhood quadruples the risk of a stroke later in life, researchers here say. ...

    Childhood cancer survivors face limitations Oct 31, 2005
    Reuters.uk, The cancers included primary brain cancer, leukemia, Hodgkin's disease, non-Hodgkin's lymphoma, kidney tumor, neuroblastoma, soft-tissue sarcoma or malignant ...

    Infections eyed as cancer cause Oct 25, 2005
    Vancouver Sun (subscription), Eighty per cent of gastric cancers are associated with the helicobacter pylori bacteria, while 20 per cent of cases of non- Hodgkin's lymphoma and Hodgkin's ...

    Biogen revises warning label for cancer drug Oct 29, 2005
    Boston Globe, ...after treatment. Zevalin is administered in conjunction with Biogen Idec's Rituxan for non-Hodgkin's lymphoma. Because potentially ...

    `Terrible error,' then a death Nov 3, 2005
    San Jose Mercury News, He said that even when he was in a Stanford hospital bed waiting to die, not from the non-Hodgkin's lymphoma with which he had been diagnosed, but from what ...

    New drug guidance plans announced Nov 3, 2005
    Daily Mail - UK, ...be docetaxel (Taxotere), paclitaxel (Taxol) and trastuzumab (Herceptin), all for breast cancer, rituximab (Mabthera) for non-Hodgkin's lymphoma, and bortezomib ...

    Tragedies jog GOP shift on stem cells Oct 22, 2005
    San Diego Union Tribune, 67 votes. When he was diagnosed in February with Hodgkin's lymphoma, a cancer of the lymph glands, Pennsylvania Sen. Arlen Specter's ...

    CAT buys part of Genencor's Health Care ops from Danisco for 14 ... Nov 1, 2005
    Forbes ...an optimised version of GCR-3888, is in pre-clinical development as a potential treatment for B-cell malignancies including non-Hodgkin's lymphoma (NHL) and ...

    Cancer patients hail speedier NHS checks on life-saving drugs Nov 3, 2005
    Guardian Unlimited, The first five drugs to undergo the new process will be Herceptin, Taxol, another breast cancer drug, MabThera, for non-Hodgkin's lymphoma, and Velcade for ...

    CAT expands drugs pipeline with $16m deal for cancer treatments Nov 1, 2005
    Independent, ...pipeline to 10. A second drug, for Hodgkin's lymphoma, is expected to be tried in man for the first time next year. CAT said yesterday ...

    FDA to speed ruling on uses of Biogen cancer drug Oct 26, 2005
    Boston Globe, Drug Administration will give speedy review to Biogen Idec Inc.'s request that Rituxan, its treatment for a specific type of non-Hodgkin's lymphoma, be used to ...

    Free Press / Flagstar Bank Marathon Oct 20, 2005
    Detroit Free Press, ...exercise. But when the non-Hodgkin's lymphoma of her son-in-law, Dean Franco, worsened this spring, Bower was inspired to take a stand. ...

    Health Wrap: Cancer takes a beating Oct 21, 2005
    Science Daily (press release) ..."Although this was an interim study, the results are very encouraging that we can cure patients with early-stage Hodgkin's lymphoma of their cancer while ...

    Pharma, biotech, post mixed finances. Oct 31, 2005
    in-PharmaTechnologist, ...to $215.1 million. Sales of Rituxan for non-Hodgkin's lymphoma rose 16 per cent to $456.2 million for the quarter. Sales were boosted ...

    Genitope Corporation to Present at Rodman and Renshaw Techvest 7th ... Nov 2, 2005
    PR Newswire (press release), ...is conducting a pivotal phase 3 clinical trial using MyVax (R) Personalized Immunotherapy in previously untreated follicular non-Hodgkin's lymphoma patients. ...

    Cougar Biotechnology Announces Presentation at Rodman & Renshaw ... Nov 2, 2005
    Genetic Engineering News, ...which has completed Phase I clinical trials in prostate cancer, CB3304, which is currently being tested in a Phase I trial in non-Hodgkin's lymphoma and CB1089 ...

    FURY AT 'FAST DRUGS' MOVE Nov 4, 2005
    Mirror.co.uk, ...new drugs will be reviewed quickly in the first wave - breast cancer treatments Herceptin, Taxotere and Taxol, MabThera for non-Hodgkin's lymphoma and Velcade ...

    Biogen marks key milestones in Rituxan tests Oct 31, 2005
    Boston Business Journal, ...after the company's late August filing. Rituxan is already approved to treat non-Hodgkin's lymphoma. But Biogen Idec is exploring ...

    Genentech, Biogen push biotech stocks higher Oct 31, 2005
    Investor's Business Daily (subscription) Rituxan is already approved to treat non-Hodgkin's lymphoma. See full story. Biogen shares advanced 6% to $40.63, while Genentech gained 3% to $90.60. ...

    Biogen, Genentech gain on Rituxan drug news Oct 31, 2005
    Investor's Business Daily (subscription) ...end of February, they said. Rituxan is already approved for the treatment of non-Hodgkin's lymphoma. The companies are seeking to ...

    Cancer-fighting drug warning level raised Oct 31, 2005
    United Press International The drug already had a warning on its label. Zevalin is used with the cancer drug Rituxan when no other treatments of non-Hodgkin's lymphoma work. ...

    FDA and Biogen Idec Issue Drug Safety Alert Concerning Fatal ... Oct 30, 2005
    Newsinferno.com, ...is indicated for the treatment of patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma (NHL), including ...

    New Survey Shows Cancer Patients Continue to Suffer From Extreme ... Oct 31, 2005
    PR Newswire UK (press release), ...solid tumours receiving chemotherapy and treatment of symptomatic anaemia in adult patients with multiple myeloma, low-grade non-Hodgkin's lymphoma or chronic ...

    ... Go to the Article Oct 14, 2005
    CancerWise ...rituximab (Rituxan®). Rituximab is a monoclonal antibody drug federally approved for use in non-Hodgkin's lymphoma. Monoclonal ...

    Spectrum Pharmaceuticals Reports Third Quarter 2005 Financial and ... Nov 4, 2005
    PR Newswire (press release), Elsamitrucin * A multicenter, Phase 2 clinical trial in refractory non-Hodgkin's lymphoma, especially in Rituxan(R) failures, is running at approximately 30 ...


    Heartfelt gratitude 10 Sep 2005
    Kimberly, of Cobram on the Murray River, was diagnosed with non-Hodgkin's lymphoma last year with a cancerous tumour engulfing her heart. ... Advertiser Adelaide,

    Drug offers hope for non-Hodgkin's lymphoma Sep 9, 2005
    ...radioactive "smart bombs" directly to cancer cells is showing great promise in treating patients with some types of non-Hodgkin's lymphoma, Canadian doctors say ... CTV.ca,

    Trial at Jefferson shows new drug may help cancer patients who ... Sep 7, 2005
    In the phase II trial, researchers were attempting to determine if patients with multiple myeloma or non-Hodgkin's lymphoma who received the drug AMD-3100 ... EurekAlert,

    Bone marrow drive can help dentist, other African Americans Sep 8, 2005
    ...in need. The 51-year-old African American dentist was diagnosed with non-Hodgkin's lymphoma and multiple myeloma in 2002. After ... Chicago Defender,

    Ros flies high in aid of cancer patients Sep 7, 2005
    ...for charity. Ros Scrope, 26, from Corbridge, Northumberland, was told she had Hodgkin's Lymphoma three years ago. But yesterday ... ic Teesside.co.uk,

    AnorMED Release: Medical journal, Blood, reports new stem cell ... Sep 6, 2005
    ...transplantation. The Phase II study included 25 patients, 10 patients with multiple myeloma and 15 patients with non-Hodgkin's lymphoma. ... Hype & Hope,

    Biogen Idec Cuts 17% of Jobs Sep 8, 2005
    The Cambridge, Mass., company's new strategy will lead it to focus on the multiple sclerosis treatment Avonex and the non-Hodgkin's lymphoma drug Rituxan. ... TheStreet.com

    Beating cancer half the battle Sep 4, 2005
    Though Smead has a healthy respect for the Hodgkin's lymphoma she contracted 21/2 years ago, she was determined to live as normally as possible through her ... Daily Press,

    Ice hockey match raises a cool £15k Sep 9, 2005
    ...of cancer. Phil was told he had Hodgkin's Lymphoma while Acocks Green resident Matt found out he had testicular cancer. But determined ... ic Solihull.co.uk,

    BioCryst to Present at the Bear Stearns 18th Annual Healthcare ... Sep 7, 2005
    Fodosine(TM) has been granted Orphan Drug status by the US Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL ... Yahoo! News (press release)

    Immunodiagnostics Shape Immunotherapeutics for Improved Cancer ... Aug 24, 2005
    ...ibritumomab tiuxetan in a stem cell transplantation-conditioning regimen is relatively safe and may improve outcome in severe refractory non-Hodgkin's lymphoma ... Medscape (subscription)

    Allos Therapeutics to Present at the Bear Stearns Healthcare ... Sep 7, 2005
    ...under investigation as both a single agent and in combination therapy regimens in patients with non-small cell lung cancer and Non-Hodgkin's lymphoma; and RH1 ... PR Newswire (press release),

    David L. Jones Sep 6, 2005
    ...in the Hanna Building until 1997, when he moved the organization to his home in Willoughby Hills after he was diagnosed with non-Hodgkin's Lymphoma which he ... News-Herald.com,

    David L. Jones, started ad agency Sep 8, 2005
    ...advertising and graphic arts agency 30 years ago and built it into a firm with clients across the country, died of complications of non-Hodgkin's lymphoma Sept ... Cleveland Plain Dealer,

    "A family is forever changed' Aug 27, 2005
    The Welches first become involved in the walk after Janey Welch was diagnosed with stage IV of non-Hodgkin's lymphoma three years ago. She's in remission. ... Savannah Morning News,

    Simple test provided cancer patient hope Sep 5, 2005
    Yaffe entered the MD Anderson Cancer Clinic in Houston in a last-ditch effort to destroy the blood cancer called non-Hodgkin's lymphoma. ... Sun-Sentinel.com,

    Bike boy, 5, crushed to death by pillar Sep 6, 2005
    The work of the Calendar Girls is dedicated to the memory of Matthew's father, John Baker, who died from non-Hodgkin's lymphoma in July 1998 aged 54. ... Leeds Today,

    Rituximab to be Considered for Front-Line Treatment of ... Aug 17, 2005
    R) (Rituximab), in previously untreated (front-line) patients with intermediate grade or aggressive, CD-20-positive, B-cell, non-Hodgkin's lymphoma (NHL) in ... RxPG NEWS,

    The San Francisco 49ers and Novacea Join Forces to Tackle Prostate ... Sep 6, 2005
    Banoxantrone, or AQ4N, is in a Phase 1 study in advanced malignancies and a Phase 1/2 study in patients with non-Hodgkin's lymphoma or chronic lymphocytic ... Yahoo! News (press release)

    Filing Based on Data From Three Phase III Trials in More than ... Aug 17, 2005
    Rituximab), in previously untreated (front-line) patients with intermediate grade or aggressive, CD-20-positive, B-cell, non-Hodgkin's lymphoma (NHL) in ... Yahoo News (press release)



    Hodgkin's disease is a type of lymphoma described by Thomas Hodgkin in 1832, and characterized by the presence of Reed-Sternberg cells.

    Unlike other lymphomas, whose incidence increases with age, Hodgkin's lymphoma has a bimodal incidence curve: that is, it occurs more frequently in two separate age groups, the first being young adulthood (age 15-35), the second being in those over 50 years old. Overall, it is more common in males, except for the nodular sclerosis variant (see below) of Hodgkin disease, which is more common in women.

    The incidence of Hodgkin's disease is about 4/100,000 people/year, and accounts for a bit less than 1% of all cancers worldwide.

    Symptoms

    Swollen, but non-painful, lymph nodes are the most common sign of Hodgkin's disease, often occurring in the neck. The lymph nodes of the chest are often affected and these may be noticed on a chest X-ray.

    About one-third of people with Hodgkin's disease may also notice some systemic symptoms, such as low-grade fever, night sweats, weight loss, itchy skin, or fatigue.

Home | About | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org